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ABSTRACT
Genetic engineering of microbes has developed rapidly along with our
ability to synthesize DNA de novo. Yet, even with decreasing DNA
synthesis costs there remains a need for inexpensive, rapid and
reliable methods for assembling synthetic DNA into larger constructs
or combinatorial libraries. While technological advances have resulted
in powerful techniques for in vitro and in vivo assembly of DNA, each
suffers inherent disadvantages. Here, an ex vivo DNA cloning suite
using crude cellular lysates derived from E. coli is demonstrated to
amplify and assemble DNA containing small sequence homologies.
Further, the advantages of an ex vivo approach are leveraged to
rapidly optimize several parameters of the ex vivo DNA assembly
methodology testing lysates from different engineered strains of E.
coli, with various buffer components and using titrations of purified
cloning enzymes. Finally, in order to complete the cloning suite, a
vector expressing the Pyrococcus furiosis (Pfu) DNA polymerase was
designed, constructed and expressed in E. coli to create a
‘functionalized lysate’ capable of ex vivo PCR. Not only do we
demonstrate ex vivo cloning methodology as a complete cloning package
capable of replacing the expensive cloning reagents currently required
by synthetic biologists, but also establish ex vivo as an overarching
approach for conducting molecular biology.
ix

Chapter 1. Introduction and Background
“What I cannot create, I do not understand”
- Richard Phillips Feynman, PhD

1.1. DNA Assembly and Synthetic Biology
Our capacity to (re)engineer living systems is linked to our ability
to physically build specific DNA molecules that encode desired
functionality and behavior. Thanks to major advances in DNA sequencing
and DNA synthesis technologies, a renaissance in genetic engineering
known as synthetic biology has sparked incredibly rapid progress in
our ability to engineer life. Synthetic biology, metabolic
engineering, systems biology and associated disciplines can be
leveraged to not only access the estimated ~100 million biological
compounds present on our planet, but create sophisticated biological
entities as molecular machines capable of replication, catalysis,
sensing and computational response1. The programmable chemistry
potentiated by recombinant DNA technologies can be harnessed to
address societal needs such as food scarcity; renewable fuel sources;
environmental remediation and protection; medicinal (and veterinary)
diagnostics and therapeutics; or defense against bioterrorism2,3.
Due to difficulties stemming from the inherently ‘analog’ nature and
complex interdependence of biochemical systems on top of the
staggering permutations of even the smallest of genetic circuits,
1

synthetic biologists have focused on the characterization,
standardization and modularity of biological parts4. Yet, to achieve
the overarching synthetic biology dream we must continue to optimize
the design-build-test engineering loop until first principles of de
novo genetic design are ascertained.
While the current bottleneck in the Synthetic biology engineering loop
lies in the design portion of the loop (since most initial designs are
not optimal and possibly not even functional), the only way to
alleviate this design bottleneck is to continue to build and test many
genetic designs. This is not just to identify adequate designs for the
application at hand, but also to inform subsequent design efforts. The
ensuing study not only presents an optimized DNA assembly methodology
significantly less expensive and/or time-consuming than current
methods, but also presents an overall approach to rapid phenotypic
characterization, optimization and alternate route for laboratory
molecular biology.
Although our ability to construct novel DNA has come a long way from
Nirenberg’s initial synthesis of a nucleic acid homopolymer5, it still
proves most cost effective to purchase DNA in small fragments or
single-stranded oligomers to assemble into larger, gene-length
products. This is particularly true when combinatorial libraries are
being constructed. Indeed, synthetic biologists often rely on
construction and thorough characterization of libraries of modular
genetic parts. For instance, characterization of promoter regions and
ribosome binding sites (RBS) has generated successful part libraries
2

capable of tuning transcriptional and translational expression of
downstream protein coding sequences6-8. Data collected from these
experiments have even produced fairly robust models capable of
rationally designing tunable parts, such as the RBS calculator9. Yet
the interplay between DNA sequence and phenotype is full of nonlinear,
epistatic and stochastic dynamics, minimizing the modularity and
reliability of genetic parts. For example, combining a highly
expressive promoter with a highly expressive RBS part may result in
very low overall protein expression. To address these problems
synthetic biologists must often rely on parts tested in a
combinatorial manner. Beyond regulatory parts for modulating gene
expression, encoding novel functions through protein engineering still
remains an undertaking of brute force necessitating generation of
extreme sequence diversity through directed evolution (requiring an
appropriate screening approach), combinatorial domain-swapping or a
synthetic metagenomics approach. In order to address the design
bottleneck of the design-build-test loop, the build and test steps
must be made extremely rapid.
Traditionally, recombinant DNA has been constructed using restriction
cloning (i.e., cutting with an endonuclease and joining with a ligase)
and DNA fragments isolated from natural sources by restriction
digestion or polymerase chain reaction. In addition to restrictionligation approaches, other site-specific recombination systems have
been employed to assemble DNA fragments with great success10. However,
genetic engineering has recently become more flexible with the use of
3

‘sequence-independent’ approaches that take advantage of the
decreasing cost of DNA synthesis11-14. In a perfect world, synthesis of
DNA would be so cheap that all DNA constructs could be synthesized in
their entirety, sequence-verified and delivered to researchers for
testing. However, current gene synthesis rates are highly limiting
often costing several thousand dollars to synthesize full-length
genes. Instead, most DNA is ordered in more cost-effective fragments
(as of this writing, single-stranded oligomers are $0.35 per base up
to 60 bases and $120 for a 750 base pair double-stranded fragment
through Integrated DNA Technologies® [IDT]) and then assembled using
overlapping homologous sequences on the ends of the oligomers in a
‘sequence-independent’ fashion.

For example, polymerase chain

assembly (PCA), a variation on the general polymerase chain reaction
(PCR), uses partially overlapping 60bp single-stranded oligomers
alternating strands of an entire gene sequence in equimolarity as a
template. These oligos are pooled and allowed to anneal and extend
into longer and longer double-stranded sequences until a complete
double-stranded gene sequence is generated. These ‘synthons’ can be
quickly inserted into a plasmid backbone by traditional sequencespecific or sequence-independent methods.

4

Figure 1.1 DNA Assembly by a Chew-back, Anneal and Repair Mechanism
Depicted are the steps employed by Gibson Isothermal assembly (ISO) and analogous
putative steps for in vivo single-strand annealing predicted to be the active
mechanism in ex vivo DNA assembly. In steps 1-3, an exonuclease (here 5’-to-3’) chews
back (resects) the double-stranded ends to expose terminal homologies (colored blue),
which can anneal to each other in step 4. If there has been excessive resection as
depicted in steps 5-6, a DNA polymerase is used to repair the exposed gaps. Finally, a
DNA ligase acts to seal the DNA backbone (7), to yield a fully sealed, accurate
assembly/repair. The table describes the tripartite mixture of enzymes in the ISO
formulation and some analogous naturally-occuring enzymes from yeast, E. coli and D.
radiodurans.

When trying to assess the function of DNA sequences in the cell, it is
of great utility to have sequence-independent cloning techniques that
do not constrain design (e.g., scars from restriction sites).
Homologous recombination is the longest-tenured sequence-independent
cloning method and the most widely utilized for integration onto the
genome. Highly active homologous recombination systems native to
Bacillus subtilis and S. cerevisiae make effective in vivo
recombination systems, while in E. coli, the Lambda Red recombinase
5

genes can greatly increase the rates of homologous recombination15. In
fact, S. cerevisiae has been utilized to assemble and propagate entire
bacterial genomes from very large overlapping fragments, through
transformation-associated recombination (TAR)16. However, the
assemblies must be designed to work with the organismal chassis and,
unless the construct is to remain in the assembly host, must be
designed to shuttle into the final host organism. The TAR cloning
process can therefore take up to eight days to get a DNA construct
into the terminal host. While monetarily inexpensive, these time
expenses are often a disappointing attribute of in vivo methodologies.
In contrast to in vivo approaches, purified in vitro systems offer
user-control, efficiency and time savings, but are often expensive to
purchase or difficult to establish in-house due to complications in
protein purification. Once established there is no denying the potency
of these systems. In 2008, a completely synthetic Mycoplasma genome
was assembled from chemically synthesized double-stranded DNA (dsDNA)
fragments (5-7 kilobase pairs each) using an in vitro chew-back
assembly method16. More recently, the mouse mitochondrial genome was
reconstructed from overlapping synthetic single-stranded
oligonucleotides (60 nucleotides each) using a three-enzyme in vitro
isothermal DNA assembly method (ISO assembly, also known as Gibson
assembly)17. Currently the most popular and efficient sequenceindependent cloning method, Gibson and colleagues discovered an
optimized mixture of a phage 5’-to-3’ DNA exonuclease, DNA ligase, and
heat-stable polymerase catalyzing highly efficient DNA end joining
6

(Figure 1.1). As the current “gold-standard” for DNA assembly, Gibson
assembly suffers from the disadvantages of most purified in vitro
systems – it is highly expensive. Distributed as a master mixture from
New England Biologicals® (through Synthetic Genomics®) each reaction
costs $15 dollars. While very efficient and taking only an hour, if
trying to assemble larger libraries of constructs this is not a costeffective route.

1.2. The ex vivo approach
The terminology ‘ex vivo’ – Latin for “out of the living” – is a
common term in organismal biology, where tissue or even full organs
are isolated from an organism with minimal perturbation of it’s
natural environment. This permits researchers more control over
conditions and access to measurements not otherwise possible (or even
ethical) in a living organism. In this manner, the “ex vivo” moniker
describes an experiment combining the advantages of an in vivo
approach and an in vitro approach.
While ex vivo experimentation is traditionally associated with organs
and tissues, the approach has a storied history in microbiology and
cellular biology. The first ex vivo reaction catalyzed by a microbial
cell extract was performed by Eduard Buchner (1897) over 100 years
ago, converting sugar to ethanol and carbon dioxide in a yeast
extract, eventually winning the Nobel Prize in Chemistry (1907). Using
lysate fractions derived through differential centrifugation,
microsomes were discovered as catalysts of protein synthesis, leading
7

to the identification of mRNA as the template for protein synthesis by
Nirenberg and Matthaei (1961) in their own extract-based reaction5. As
history and technology progressed the microbiology and cellular
biology systems derived from cellular extracts have become popularly
referred to as ‘cell-free systems’ (CFS). However, ‘cell-free system’
is an umbrella term giving very little detail to the composition of
the final system. For instance, cell-free systems for protein
synthesis range from crude extract to systems reconstituted in vitro
with entirely purified components. For this reason, we propose ex vivo
be used to describe a CFS which is minimally altered from its’ in vivo
origins by only very crude purification or manipulation (e.g.,
centrifugation of insoluble components).

1.3. Applications of Cell-Free Systems
Since their inception, CFSs have primarily been leveraged to probe the
central processes of transcription and translation. Over the past ~25
years, building off work establishing coupled transcriptiontranslation CFS18, modern CFS have evolved into robust systems capable
of high-level protein production. Recent work with E. coli-based
extracts have garnished yields exceeding 2 mg/mL protein at scales
exceeding 100 liters19. Complex eukaryotic proteins containing highlevels of post-translational modifications can be produced in cellfree extracts from wheat-germ, rabbit reticulocytes and insect cells
at high titers. This is important, since CFSs obviate the need to
perform in vivo manipulations that can be difficult or impossible in
some eukaryotic cell lines. Cell-free protein production is therefore
8

particularly attractive to industrial production of therapeutic
peptides as they are commonly post-translationally modified, exist
associated with the membrane or may exhibit toxicity (e.g.
antimicrobial peptides).
For synthetic biology, CFSs have been cleverly employed to expedite
the prototyping of genetic parts for gene expression. By monitoring
the production of fluorescent proteins in a CFS the time investment
and noise (i.e., plasmid copy number) associated with in vivo
characterization is greatly reduced. Although not an absolute perfect
measure of in vivo dynamics, a set of constitutive and inducible
promoters tested in a CFS were shown to correlate well with
measurements of in vivo gene expression and dose-response20.
Cell-free protein synthesis has benefited greatly from advances in
mimicking intracellular conditions, activating integrated biological
processes and controlling cell-free metabolism. Control over
metabolism in CFSs has motivated the development of CFSs as platforms
for the synthesis of metabolites. Although most of these higherfunctioning CFSs require further purification of the pathway
constituents from the lysate, in a truly excellent demonstration of an
ex vivo system, Panke and colleagues optimized the catalysis of
dihydroxyacetone phosphate (DHAP) from glucose21. The authors were able
to reach concentrations far beyond those documented in vivo (12 mM
DHAP) by deletion of two genes in the production strain combined with
supplementation of butanol and rabbit muscle aldolase to the reaction.
DHAP is an unstable product, but the exogenous addition of the
9

aldolase and butanol allowed conversion to a more stable form. This is
a perfect example of the simplicity and flexibility of CFS
optimization, not only by modification of the host chassis, but also
by circumventing the membrane to directly supply new components (here
the small-molecule butanol and a non-bacterial enzyme) impossible in
the same in vivo system.
The constant struggle between the engineering objective to optimize
product yield and the cell’s biological objective to optimize biomass
production is remedied by an ex vivo approach. The functionalities of
the cell remain intact, while removal of the cell encapsulation
enables manipulation of the internal chemistries to activate,
integrate and focus cellular resources towards a desired objective.
Without compartmentalization there is the opportunity to greatly
exaggerate substrate concentrations, remove product, and rapidly
sample and monitor reaction conditions. In in vivo systems researchers
and engineers must respect the constraints, time-scales and
stochasticity inherent to life. On the other hand, purified in vitro
systems provide exceptional flexibility and control, resulting in
higher reaction efficiencies and better reproducibility. Yet, in vitro
systems are low-throughput and orders of magnitude more expensive than
their in vivo counterparts. This is clearly demonstrated in the
production of cellulosic biofuels, where the primary cost-driver is
the expense of purified enzymes for biomass pretreatment22,23. For
investigators, in vitro systems sacrifice cellular context necessary
to make conclusive inferences about in vivo phenomena. A simple, yet
10

elegant compromise between in vivo and in vitro approaches, ex vivo
systems enhance both engineering and investigatory freedom.

1.4. Double-strand Break Repair: Natural DNA Assembly
The end-to-end joining of free dsDNA fragments is a vitally important
process for all cellular life in the repair of double-stranded DNA
breakage. DNA double-stranded breaks (DSB) are ubiquitous across all
kingdoms of life, occurring during normal housekeeping functions and
in response to DNA damaging agents such as chemicals and
irradiation24,25. Very simply, a DSB is a break in both strands of
duplex DNA. A DSB is a particularly dangerous DNA lesion as these
breaks can potentially disrupt gene expression, alter chromosome
organization or provide substrates for single- or double-stranded
exonucleases, catalyzing the deletion of genetic information. DSB are
also notoriously difficult to repair. Where a single-stranded break
can be easily repaired using the conserved information on the intact
strand, generally DSB have no associated template at the free ends to
guide repair. Due to these two reasons DSB repair is widely associated
with the development of cancer and has, therefore, been the subject of
extensive study26,27. There are two major mechanisms for DSB repair:
end-joining and homologous recombination. The major distinction
between the two being that the former requires no template to
facilitate repair of the DSB. The presence of template DNA is,
therefore, essential in the decision and mechanism of DSB repair
pathways.
11

1.4.1. Homologous Recombination
Homologous recombination generally leads to high-fidelity repair,
making it the most ubiquitous and dominating DSB repair pathway across
organisms. However, unlike end-joining, homologous recombination’s
requirements for a template means that a second copy of the region
containing the DSB must exist in the cell. For most prokaryotes, this
is not a problem as they often exist with multiple or, at least,
partial copies of their genome. In eukaryotes, homologous
recombination is reserved for the S and G2 phases of the cell cycle
when sister chromatids are present, acting as template for repair and
meiotic crossing-over.
1.4.2. Non-homologous End-Joining
End-joining implies the linking of two free duplex DNA termini into a
ligated product. Traditionally referred to as non-homologous endjoining (NHEJ), the relatively simple process relies on minor
processing of DNA termini to prepare them for direct ligation in the
absence of any required homologous template. While this means that
repair can take place at any point during the cell cycle regardless of
genome copy number, the fidelity of repair is relatively low. Errors
are often propagated from loss-of-information during end processing
(resection), explaining the relatively low occurrence in prokaryotes
in comparison to homologous recombination. In higher eukaryotes, the
error-prone nature of NHEJ has evolved into a highly coordinated
system to generate sequence diversity in the differentiation of unique
12

B- and T-lymphocytes. More recent studies have revealed ‘alternate
end-joining’ or ‘microhomology-mediated end-joining’ pathways
utilizing repeat sequences at or near the terminus of DSBs, such as
those that may occur in breaks near or within ribosomal operons of
prokaryotes28,29.
1.4.3. Alternative End-Joining
Alternative end-joining pathways appear to exist in a grey-area
between the extremes of NHEJ and homologous recombination relying on
combinations of cellular machineries from both processes,
distinguished by the degree of available homologous template. Outside
of rare circumstances, like the ribosomal operon described above, a
DSB is very unlikely to form with significant end homologies to guide
non-templated repair. Nevertheless, an alternative DSB repair pathway
known as single-strand annealing (SSA) exists to join DSB with
significant homologies at their termini30. As in the homologous
recombination process, SSA involves an extensive end-resection to
expose single-strand overhangs31. Yet, in contrast to homologous
recombination, these ends subsequently anneal to the newly exposed
homologies on the cognate DSB for a final step of ligation (similar to
NHEJ). SSA is a mechanistic analog to the Gibson ISO assembly method
(Figure 1.1), following the same chew-back (resection), annealing,
polymerization and ligation steps, but occurs (albeit infrequently) in
completely wild-type microbes. Hopefully, by freeing and concentrating
the enzymes necessary for SSA end joining of overlapping DNA fragments
will take place. E. coli, and S. cerevisiae make good chassis not only
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due to preliminary research suggesting they are capable of catalyzing
end joining in an extract-based reaction, but their relatively easy
culturing methods and availability to most labs13,32. D. radiodurans
makes another excellent chassis for exDA, as it is known to have some
of the most active DNA repair systems, making it the world’s (current)
most radioresistant organism33.

1.5. The ex vivo Cloning approach
In the ensuing study, we endeavored to demonstrate the facilities of
the ex vivo approach to demonstrate and subsequently investigate and
optimize DNA assembly. Using our own assays of assembly we tested
lysates prepared from different organisms and strains, under varying
growth conditions and with variable buffer/reaction conditions.
Titrations of common cloning enzymes were employed to investigate the
underlying enzymatic mechanisms of DNA assembly. Applying genome
engineering techniques we endeavored to engineer a new strain of E.
coli lacking competing nucleases and capable of autolysis for ex vivo
DNA assembly. We designed and constructed pUN (‘plasmid unique
neutral’) a novel plasmid featuring a screenable blue chromogenic
protein (BCP) insert and ‘unique neutral sites’ for facile cloning via
ex vivo DNA assembly or other sequence-independent assembly methods.
Lastly, using our new pUN plasmid we replaced the BCP insert with a
cassette expressing a codon-optimized Pyrococcus furiosus (Pfu) DNA
polymerase gene. This plasmid yields a lysate with high levels of the
thermostable DNA polymerase now ‘functionalized’ to perform a highfidelity ex vivo PCR reaction. With ex vivo methods for both DNA
14

assembly and PCR we report the creation of the first all-encompassing
ex vivo Cloning pipeline.
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Chapter 2. ex vivo DNA ASSEMBLY
Data and Figures reproduced with permission from:
Fisher AB, Canfield ZB, Hayward LC, Fong SS and McArthur GH IV (2013) Ex vivo DNA
assembly. Front. Bioeng. Biotechnol. 1:12. doi: 10.3389/fbioe.2013.00012
Author Contributions:
George H. McArthur and Adam B. Fisher designed the experiments, which were carried out
in the laboratory of Stephen S. Fong. Adam B. Fisher performed the experiments with
Zachary B. Canfield and Laura C. Hayward. George H. McArthur, Adam B. Fisher, and
Stephen S. Fong interpreted the data and wrote the manuscript. All authors discussed
results and commented on the manuscript.

2.1. Initial 2-way ex vivo DNA Assemblies
To assess the ability of select cellular lysates to join together
dsDNA, we first designed two amplicons with appropriate overlapping
ends (26 and 30 bp overlaps) to be assembled into a circular plasmid
(Figure 1.1A)34. Correctly assembled plasmids endow E. coli
transformants with selective resistance to the antibiotic
chloramphenicol and also visually screenable expression of a blue
chromogenic protein (BCP) native to the coral Acropora millepora
(Figure 1.1B)35. Template plasmids housing the bcp coding sequence
(pSB1C3-K592009) and the appropriate antibiotic resistance and
replication origin (pSB1C3-J04450) produce white and red/pink
colonies, respectively, providing a convenient way to track
transformation efficiencies (Figure 1.1B).
In this initial experiment, we used lysates of S. cerevisiae, E. coli,
and D. radiodurans (hereafter Sce, Eco, and Dra, respectively) and a
simple buffer containing ATP and MgCl2 to attempt ex vivo DNA assembly.
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The two amplicons were incubated for 1 hour with each lysate. Samples
of each reaction mixture were subsequently used to transform E. coli
NEB10β.

Figure 2.1 The 2-way Circular Assembly
(A) 2-way assembly was demonstrated by joining a coding sequence for blue chromogenic
protein (BCP; a 698 bp segment of pSB1C3-K592009 colored in dark blue) and the
majority of pSB1C3-J04450 (a 2446 bp segment), thereby replacing the RFP coding
sequence with BCP (pSB1C3-BCP). The pMB1 origin is colored in green and the
chloramphenicol resistance gene is colored orange. (B) Correctly assembled plasmids
allow transformants to express BCP (blue colonies) while colonies containing carryover
template plasmids appear either red (pSB1C3-J04450) or white (pSB1C3-K592009).

Interestingly, Dra-incubated DNA did not produce transformants,
although DNA incubated with Sce or Eco successfully transformed E.
coli. Further analysis by agarose gel electrophoresis showed
significant degradation of the individual amplicons, indicating that a
highly active exonuclease system might have prevented the assembly of
DNA by Dra (Appendix B Figure B.1). Even expected background
transformants resulting from lingering circular PCR template were
absent, suggesting that endonuclease activity is also high in Dra.
Indeed, after further investigation we found a consensus DrdI site
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(GAC-N6-GTC) between 1475 and 1486 (GACGCTCAAGTC) in the replication
origin of our plasmids36.

2.2. Testing the Magnesium:ATP Ratio with 2-way Linear
Assemblies
We then explored ways to improve the efficiency of ex vivo DNA
assembly with Eco and Sce by varying the relative composition of ATP
and MgCl2 in our buffer, adding NAD to the buffer (to power NAD+dependent processes such as ligation), modulating the temperature at
which the reaction mixture was incubated, increasing the amount of
cellular lysate in our reaction, and increasing the duration of
incubation. To directly assess the efficacy of ex vivo DNA assembly
and avoid variation associated with transformation, we chose to
visualize formation of a linear product (Figure 2.2A) from a pair of
overlapping amplicons (28 bp overlap) via agarose gel electrophoresis
of the ex vivo assembly reaction prior to transformation (Figure
2.2B). In this manner, we were able to compare different reaction
conditions on their ability to join two overlapping dsDNA into one
linear product.
Buffers were made of 1 mM DTT, 1 mM NAD, and varying concentrations of
ATP and Mg+2. A wide range of ATP:Mg+2 ratios were initially tested with
1-hour Eco reactions at 37°C: 1:5, 1:10, 1:20, 5:5, 5:10, 5:20, 10:5,
10:10, and 10:20 (mM:mM). Only three ATP:Mg+2 ratios were chosen for
further reaction optimization: 10:5, 5:5, and 1:10 (mM:mM) (buffers 1–
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3 in Figure 2.2B, respectively). Linear products resulting from
assembly by Sce were not at all visible in the gel, although bands of
small pieces of DNA indicate that there is some nuclease activity
under most conditions tested. On the other hand, Eco appears to have
significant activity at 30°C and 37°C even without the addition of
buffer. Previous studies have noted that the nucleolytic behavior of
the RecBCD complex of E. coli changes based upon the relative amount
of ATP to free Mg+2in vitro
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. We observed a similar trend in our

lysates; the most efficient assembly reactions (for both 30°C and
37°C) were carried out under conditions of excess magnesium relative
to ATP (Buffer 3 in Figure 2.2B), probably because ATP can chelate Mg+2
with high affinity under physiological conditions
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Figure 2.2 The 2-way Linear Assembly and Buffer Optimization
(A) Optimized ex vivo reaction conditions were identified by visualizing the joining
of a 697 bp segment of pSB1C3-K592009 (BCP) and a 381 bp segment of pSB1C3-J04450
(Promoter) into a larger linear DNA molecule. (B) Reactions were run for 1 and 2 h
(left and right in each gel, respectively), at three temperatures and four buffer
compositions for each Eco and Sce. All buffers contained 1 mM NAD and 1 mM DTT. ATP
and Mg2+ concentrations(mM:mM)varied as follows:(1)10:5,(2)5:5,(3) 1:10. The control
lanes include a reaction with no supplemented buffer (−) and a negative control
(“ctrl”) DNA-only lane (no buffer or lysate).

Each ex vivo reaction condition was tested for both 1- and 2-hour
incubations. Initial experiments indicated that greater incubation
times (3–6 hours) do not improve ex vivo assembly yields (data not
shown). For all successful assemblies, 2-hour reactions appear to
generate more linear product than 1-hour reactions. The temperatures
selected for ex vivo reaction optimization reflect cell culture
conditions (30°C for yeast and 37°C for E. coli) and the temperature
used for ISO assembly reactions (50°C). The 50°C reactions are
considered a negative control since we do not expect the cellular
machinery in Eco or Sce to be thermostable, although transient
activity may occur initially. Based on the results of these
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experiments we selected a buffer composition of 1 mM ATP, 10 mM Mg+2, 1
mM DTT, and 1 mM NAD+ (i.e., Buffer 3 in Figure 2.2B) incubated at
37°C for 2-hour as our optimized conditions for both Eco and Sce.

Figure 2.3 The 3-way Assembly and Colony Counts
(A) Three-way assembly was demonstrated by joining the BCP coding sequence (a 696 bp
segment of pSB1C3-K592009), the majority of a plasmid carrying a different antibiotic
resistance gene (a 2214 bp segment of pSB1K3-J04450) and a promoter-RBS region used to
drive BCP expression (a 387 bp segment of pSB1C3-J04450), resulting in pSB1K3-BCP.
(B,C) The pMB1 replication origin is colored in green, the chloramphenicol resistance
gene is colored orange and the kanamycin resistance gene is colored purple. Colony
counts for optimized two- and three-way assembly experiments. The negative control
assembly reaction is labeled “None” meaning that these colonies result from in vivo
assembly in E. coli.

2.3. Optimized Assemblies with Yeast and E. coli Lysates
Under optimized reaction conditions, Eco and Sce were used again to
perform the two-way dsDNA assembly. In addition, we designed three
overlapping amplicons (30, 29, and 26 bp overlaps) to demonstrate a
three-way assembly, which is not only more complex but also more
useful for generating combinatorial libraries (Figure 2.3A). For each
of these assembly tests, lysate-incubated DNA was allowed to react for
2-hours before transformation of E. coli. Control conditions of zero
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incubation time and reactions with no lysate added were also run to
ensure that the lysate was indeed facilitating DNA assembly and not
otherwise affecting the transformation process.
Our results (Figure 2.3B and Figure 2.3C) clearly indicate that DNA is
indeed being assembled ex vivo. For two- and three-way assemblies,
both Eco and Sce, transformation efficiencies significantly increase
when the DNA to be assembled is allowed to incubate with the lysate.
Unexpectedly, the “no lysate” negative control revealed that for twoand three-way assemblies the overlapping amplicons can be joined
together into a circular plasmid in vivo, suggesting that a
significant fraction of the ex vivo assembly reactions – and also in
vitro reactions (e.g., ISO assembly) – actually occur inside E. coli
after transformation (i.e., transformation-associated recombination
cloning in E. coli). Although Eco-mediated assembly produced many blue
colonies for both two- and three-way assemblies (423 and 491 colonies,
respectively), Eco-lysate appeared to be detrimental to the overall
transformation efficiency as when transformation reactions were spiked
with Eco-lysate (but not allowed to incubate with the DNA amplicons)
the presence of colonies was greatly diminished (See, Table 2.1).
2.3.1. Effect of Detergents on Transformants
To test whether or not the detergent-based lysis buffer used to
produce Eco was affecting the transformation process, we carried out
the assembly reactions and transformations in the presence of the
lysis buffer but without cellular lysate. As summarized in Table 2.1,
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the bacterial lysis buffer inhibits transformation completely.
Therefore, Eco-mediated assembly is likely much more efficient than we
have observed and an alternative lysis method would probably increase
overall transformation efficiency. The yeast lysis buffer does not
appear to inhibit transformation of E. coli, which is not surprising
because it is designed to lyse yeast cells. Interestingly, the number
of colonies produced by DNA incubated with yeast lysis buffer was
equivalent to the number of colonies produced by Sce-incubated DNA and
that produced by the “no lysate” control. These data suggests that
Sce-mediated DNA assembly was not observed but rather indicates that
in vivo end joining in E. coli facilitates DNA assembly in this case.
Interestingly, there would appear to be an increase in total colonies
formed when the DNA is incubated with CelLytic Y. One might speculate
that during incubation perhaps the buffer composition influences the
DNA to adapt a more tightly supercoiled conformation as is seen in
solutions with higher salt concentrations and is observed to greatly
increase transformation efficiency39,40. However, without further
experimentation and knowledge of the proprietary CelLytic Y formula
this remains purely speculative.
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Table 2.1. Effect of Detergents on Assembly and Transformation
2-way ex vivo circular DNA assembly
Lysis Buffer

Reaction time

# Colonies

# Blue

# Red

# White

CelLytic B

0 minutes

0

0

0

0

CelLytic B

120 minutes

0

0

0

0

CelLytic Y

0 minutes

42

41

0

1

CelLytic Y

120 minutes

150

140

0

10

3-way ex vivo circular DNA assembly
Lysis Buffer

Reaction time

# Colonies

# Blue

# Red

# White

CelLytic B

0 minutes

0

0

0

0

CelLytic B

120 minutes

0

0

0

0

CelLytic Y

0 minutes

15

8

7

0

CelLytic Y

120 minutes

27

18

9

0

Tabulation of colony counts for transformations that were carried out in the presence
of lysis buffer and the appropriate DNA but without cellular lysate. No transformants
were seen when the DNA was incubated with the bacterial lysis buffer (CelLytic B),
suggesting that this particular buffer somehow inhibits transformation. On the other
hand, the yeast lysis buffer (CelLytic Y) showed no inhibition of transformation,
which may not be surprising since the bacterial lysis buffer is designed to act on
bacteria such as E. coli NEB10β. However, it is also clear from these results that Sce
does not offer any advantage over the yeast lysis buffer for DNA assembly and,
therefore, it can be deduced that the transformants resulting from Sce incubation are
actually a result of in vivo DNA assembly in E. coli.

2.4. Conclusions and Discussion
Through a series of experiments investigating circular and linear DNA
assembly, we found that: 1) lysate derived from E. coli NEB10β, a RecAdeficient strain, was able to efficiently assemble dsDNA, 2) a
fraction of the assembly takes places inside E. coli NEB10β posttransformation by in vivo DNA assembly, and 3) lysates derived from D.
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radiodurans and S. cerevisiae were not able to join together dsDNA
under the conditions we tested. In addition, it is worth noting that
we attempted single-stranded DNA (ssDNA) assembly of synthetic 60-mer
oligonucleotides (20 bp overlaps) that was accomplished by ISO
assembly but was unsuccessful using our ex vivo approach (data not
shown). Over the course of all of our experiments we found that the
trends in efficiency of assembly held true across organisms
independent of batch-to-batch variation.
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Chapter 3. Optimization of ex vivo DNA
Assembly
3.1. Lysate Preparation
Arguably, the most important step in any ex vivo investigation is the
preparation of the lysate. Since this starting material may be used
for many subsequent reactions and experiments it is critical to fully
investigate the factors contributing to the suitability of resulting
cell extracts prior to optimizing downstream reaction parameters. To
investigate lysate preparation we tested the effects of varying media
composition, harvesting at different points in the growth curve, the
addition of cryopreservant (i.e., glycerol) and lysis method.
3.1.1. Harvest Phase
The typical growth curve of E. coli (and other prokaryotic bacteria)
show an initial period of non-exponential growth (known as lag phase)
in which the cells adjust their intracellular physiology in response
to the change in extracellular conditions and the increase in
available nutrients. This is followed by the exponential phase in
which the cells reproduce at maximal capacity (given the external
conditions) until the external environment becomes suboptimal (due to
culture density, accumulation of waste/byproducts or depletion of
nutrients). At this point the cells transition from exponential phase
into a quiescent state known as stationary phase (SP). Reproduction is
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halted and metabolism is severely slowed as the cell allocates
resources to only the very most essential processes until new
resources become available and the whole grow curve can restart.

1.8
1.6

Fold Differnce

1.4
1.2
1
0.8
0.6
0.4
0.2
0
Early Exponential

Late Exponential

Stationary Phase

Figure 3.1 Harvested Growth Stage on Assembly Efficiency
NEB10β was grown in TB and harvested at various points along the growth curve. Growth
phase was judged by optical density at 600 nm, using absorbances of 0.4, 1.0 and >2.0
as markers of early exponential, late exponential and stationary phases, respectively.
Lysates were prepared as previously reported using detergents and two-way assemblies
performed. Fold difference represents the change in product band intensity of the
sample as compared to the intensity of Stationary Phase product band. Band intensities
are calculated relative to the BCP band of the negative control lane. Original gel
picture are shown in Figure B.2 and Figure B.3.

Initial experimentation with ex vivo DNA assembly grew the E. coli
cultures to saturation for two reasons. First, this is very convenient
for the researcher as the E. coli culture can be prepared as an
overnight culture and grown to saturation by the next day without the
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need to constantly monitor the progress of the culture. Second, during
the later stationary phase of growth the cell and genome are bombarded
by accumulated waste products (free radicals, high pH)41,42. The damage
inflicted upon the cellular DNA may thereby cause the cell to produce
DNA repair enzymes useful for DNA end joining. However, the highest
levels of DNA replication occur during exponential phase and may in
fact contain elevated concentrations of DNA repair enzymes useful to
DNA assembly.
Based on previous observations of growth for NEB10β, we defined three
different phases of growth, Early Exponential (EE), Late Exponential
(LE) and Stationary phase (SP) represented by spectrophotometric
measurements of optical density at 600 nm (OD600) of ~0.4, ~1.0 and
>2.0, respectively. After harvesting the NEB10β grown to EE (OD600 =
0.46), LE (OD600 = 0.92) and SP (OD600 = 2.75) in previously detailed
culturing conditions, lysates were prepared by resuspending in a 3:1
ratio of 2X CelLytic B (Sigma) detergent to pellet mass (e.g., 300 µL
CelLytic for 100 mg of cell pellet), pelleting cell debris from lysis
and diluting the soluble fraction 50% with glycerol.
The results of 2-way linear assemblies using these lysates displayed
in Figure 3.1 shows an improvement in EE and LE harvesting over lysate
prepared from SP. However, this improvement is very slight. Since
harvesting in the latter stages of growth affords more biomass (and
therefore lysate) and is convenient for the researcher we will
continue to harvest in the stationary phases of growth.
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3.1.2. Rich (TB) versus Minimal (M9)
Cellular physiology is inextricably linked to the extracellular
environment. In a laboratory setting the extracellular environment is
established by the physical (e.g., temperature and pressure) and
chemical conditions of the growth medium. Under optimal conditions, E.
coli will consume metabolites to increase biomass and replicate as
quickly as possible. Conversely, under nutrient-limited or suboptimal
conditions E. coli will reproduce at a more conservative rate as
resources are reallocated to deal with environmental challenges. The
rate of growth and extracellular conditions directly impact the
production of enzymes involved in DNA reproduction and repair –
including those putatively involved in the ex vivo DNA assembly
process.
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Figure 3.2 Rich (TB) versus Minimal (M9) media
Lysates prepared from cells grown in rich and minimal medias also show minimal
difference in assembly efficiency, although minimal media showed a slightly larger
increase in efficiency. Here, late exponential cultures had to be used because
cultures grown in M9 media had trouble exceeding optical densities of 2.0 used as the
marker of stationary phase. Fold difference represents the change in product band
intensity as compared to Stationary Phase. Band intensities are calculated relative to
the BCP band of the negative control lane. Original gel pictures are shown in Figure
B.2 and Figure B.3.

Previously, we grew our E. coli cultures to stationary phase (SP) in
Terrific Broth (TB), a rich media very similar to the standard LuriaBertani (LB) media but containing increased amounts of tryptone and
yeast extract, glycerol as an added carbon source and a phosphatebased buffer system. This rich media allows growth to a much higher
saturation than typical media such as LB. While we have used other
rich media (LB, SOB, SOC; Data not shown) to prepare active lysates,
here the activity of lysates prepared in TB were compared to those
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prepared in M9 minimal media with glucose. As its name implies, a
minimal media contains only the minimum nutrients necessary for
bacterial growth, usually salts providing essential elements
(Magnesium, Sulfur, Phosphate, etc…), a carbon source (e.g., glucose,
sucrose, succinate) and water. In a minimal media environment nothing
is “supplemented” to the cell so that all the essential metabolic
pathways are active.
Given that the NEB10β lysate appeared to have slight improvements in
efficiency when harvested in LE and that when grown in M9 media NEB10β
had trouble achieving cellular densities similar to that of our
stationary phase cells grown in TB (OD600>2.0), we compared cells
grown M9 to LE with cells grown in TB to LE. As in 3.1.1, the results
of the 2-way linear assembly are interpreted as fold difference to
lysates prepared in TB at SP. The lysates prepared in M9 media at LE
show comparability with that of cells grown in TB to LE.
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3.1.3. Lysate Storage
Table 3.1 Characteristics of Protein Storage Methods
Storage Condition
Lysophilized

4°C

50% Glycerol
Solution at
-20°C

Frozen at
(usually at
-20°C or
-20°C or
-80°C
-80°C)

Typical Shelf
Life

Days to several
weeks

6 months to 2
years

Many years

Many years

Requires
sterility or
antimicrobial
agent?

Yes

Usually

No

No

Number of times
sample may be
removed from
storage

Many

Many

Once

Once

Proteins are a highly heterogeneous class of biological macromolecules
with activities that are extremely dependent upon both their chemical
composition and tertiary structure. Some proteins are even dependent
upon their association with one or more other peptides. As such,
maintaining the stability and activity of proteins outside of their
native context can be challenging. If certain conditions are not
adhered proteins may lose activity as a result of aggregation,
proteolysis/microbial contamination and exposure to suboptimal
thermochemistry. While the optimal conditions for storage vary between
proteins43, Table 3.1 highlights several general guidelines for protein
storage and stability.
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Figure 3.3 Glycerol negatively affects lysate activity
From the same NEB10β lysates prepared at various growth stages, aliquots were saved
prior to glycerol dilution and instead diluted with water. These are compared with
their glycerol counterparts and show a significant improvement in assembly efficiency.
Fold difference represents the change in product band intensity of the non-glycerol
sample as compared to its glycerol-containing counterpart. Band intensities are
calculated relative to the BCP band of the negative control lane. Original gel
pictures are shown in Figure B.2 and Figure B.3.

For our purposes, once the soluble fraction of our crude lysate is
isolated, we dilute with an equal volume of 100% glycerol and store
the samples at -20°C. To evaluate the prudence of glycerol addition,
Figure 3.3 shows the results of testing freshly prepared NEB10β
lysates diluted with either an equal part glycerol or equal part
water. Glycerol would appear to have a significant impact on assembly
efficiency, decreasing the formation of linear product approximately
four-fold.
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While such a drastic effect on DNA end-joining might be attributed to
enzymatic origins (reduction in exonuclease, polymerase or ligase
activities), it is interesting to note that there does not seem to be
a difference in the degradation bands formed with or without the
presence of glycerol. This means that a roughly equivalent amount of
substrate ends are formed by the action of exonucleases, but these
compatible substrates are not incorporated into the final product
band. Granted, it could be that while the total degradation is
equivalent the exonuclease is functioning differently. For example,
restriction enzymes are known to have reduced substrate specificity
(so called, “star activity”) for particular DNA sites in the presence
of glycerol concentrations exceeding 5%44. It would appear that the
glycerol might be interfering with the thermodynamics of base pairing
between exposed homologous regions. This could make sense given that
glycerol is able to decrease the hydration sphere around
polynucleotides by competing with water to hydrogen bond with exposed
base side groups and, perhaps for this reason, is used in
electrophoretic buffers to help prevent DNA entanglement45. Indeed,
prior investigation into ligases have shown that the electrostatic
reduction of hydrogen bonding interactions experienced with increasing
glycerol decrease the activity of the ligase but actually lead to an
increase in the accuracy/specificity of the ends ligated together46.
Although omitting the inclusion of glycerol is tempting due to it’s
clear detrimental effect on lysate activity, it’s faculty as a
cryopreservant provides convenience that – in our opinion – supersedes
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this disadvantage. For instance, if glycerol was to be omitted from
the lysate there are a few alternatives. Lysate could be aliquoted
into tubes, frozen and only thawed immediately prior to use. However,
this may be very wasteful as only 2 µL of lysate is needed per
reaction so there is either a waste of freezer space as small aliquots
are frozen in individual tubes or a waste of lysate as leftover thawed
lysate is discarded. Lysates could also be freshly prepared before all
assembly reactions; however, this is laborious and requires a culture
of E. coli to be prepared ahead of time. For these reasons we have
decided to continue to utilize glycerol as a cryopreservant agent and
maximize the efficiency of lysis in order to have a very concentrated
lysate. This way the lysate may be diluted prior to the reaction and
thereby the final concentration of glycerol is diluted, as well.
3.1.4. Detergents versus Autolysis
In the previous section we noted that ultimately, it is desirable to
have a concentrated lysate stock, which can be diluted prior to the
assembly reaction. In the previous context it was in reference to
reducing glycerol contamination, but concentrated protein samples are
also more resistant to deactivation and loss due to interactions with
the storage vessel. Generating a highly concentrated cell extract is
predicated upon an efficient lysis method.
Our current approach relying upon a chemical detergent means of lysis
is efficient, compatible with small sample volumes and requires no
specialized equipment. The detergents are non-toxic, non-denaturing
and available as 1X, 2X and 10X concentrated formulations, so an
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increased concentration can be employed to make even more highly
concentrated cell extracts. However, the detergents suffer from
several major drawbacks including the expense of purchase, a lack of
transparency to their proprietary formulation and most of all,
extensive toxicity toward the fragile competent E. coli utilized for
transformation (Table 2.1). To address this major dilemma, we decided
to investigate alternative methods to lyse our E. coli cultures.
While a number of methods are commonly employed to lyse E. coli most
are unsuitable. Thermochemical methods such as alkaline lysis and
heat-lysis denature the necessary catalytic proteins and present
conditions that may handicap downstream processes. On the other hand,
physical methods of lysis using a bead basher, French press
homogenizer or sonicator offer some of the highest lysis efficiencies
with the greatest degree of flexibility in buffer composition, but may
have minimum sample volumes, require vigilance to prevent denaturing
of the sample and all require the purchase of specialized equipment.
In response to the pitfalls inherent in each of the previous lysis
methods, Zymo Research™ has created autolytic strains of E. coli.
These strains contain an ingenious genetic design drawing upon the
lysogenic system of the E. coli λ bacteriophage. Briefly, during the
lytic phase of the λ bacteriophage life cycle the bacteriophage
expresses two proteins. One protein (protein ‘R’) is an
endolysin/lysozyme capable of cleaving the peptidoglycan bounds found
in the cell wall47. The other protein is a holin (protein ‘S’) that –
as its name implies – punches holes in the cell membrane48. Not only
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does this disrupt the osmotic balance maintained by the selective
permeability of the cell membrane but also releases the endolysin ‘R’
protein into the extracellular space where it can act upon the cell
wall. In the XJa design the autolysis cassette only contains the
endolysin ‘R’ gene that is driven by the araB promoter from the
arabinose degradation operon. By adding arabinose (at ~0.2%) to the
growing culture, the endolysin is produced at high level within the
intracellular milieu where it is prevent by the cell membrane from
acting upon the cell wall. Once ready, the researcher can freeze and
thaw the culture (resuspended in buffer of choice) in order to lyse
the culture. During the freezing of the cell, intracellular water
crystallization damages the cell membrane performing the functions
typical of the holin and releasing the endolysin to degrade the cell
wall and lyse the cell.
This autolysis cassette presents a unique approach to create a lysate
in the buffer of choice, without expensive reagents or equipment and
in a highly efficient fashion (Zymo reports lysis efficiencies >90%
after one freeze-thaw cycle for the XJa strain)49. As such, we
purchased the XJa strain that is derived from the ubiquitous cloning
strain JM109. While this strain is genotypically different from
NEB10β, from a phenotypic perspective as it relates to DNA, they are
very similar. Like most cloning strains, JM109 (XJa) and NEB10β have
mutations in endA and recA disrupting their endoplasmic DNA-specific
endonuclease and homologous-recombination functions, respectively50,51.
The endA mutation is important for protecting the integrity of any
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substrate DNA present in the lysate. In its natural context the in
vivo secretion of EndA prevents the degradation of host episomal or
genomic DNA, but once the membrane is lysed and removed in an ex vivo
or in vitro context, any substrate DNA existing or subsequently added,
assembled or circularized is an active substrate to be cleaved52,53. The
recA mutation disrupts the cell’s ability to perform homologous
recombination between repetitive sequences. This way episomal
(plasmid) DNA is maintained as intended rather than recombined with
themselves, other plasmids or the genome54,55. In addition they both
have their restriction systems removed. Strain genotypes are displayed
in Table A.2 with an explanation in Table A.3.
To test the XJa autolysis for DNA assembly, we performed the growth
experiments used for NEB10β and found that XJa performed similarly in
2-way linear experiments to NEB10β (Figure B.2 and Figure B.3). Based
on the results of the lysate negative controls from Table 2.1 the
effects of autolysis lysates on electroporation were studied first.
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Figure 3.4 Detrimental effects of detergents on electroporation
3-way assemblies were performed using basic buffer and XJa autolysed or XJa detergent
lysed and transformed into in-house prepared chemicompetent or electrocompetent
NEB10β. (A) Colony forming units represent all colonies, regardless of color. (B) Fold
improvement between colonies formed using electroporation versus chemical
transformation. Error bars represent standard error of the mean for reactions
performed in triplicate (N=3).

Using two 3-way assemblies, one performed using a detergent-derived
XJa lysate and one using an autolysis-derived XJa lysate, the
resulting assemblies were transformed into in-house prepared
chemicompetent and electrocompetent NEB10β. The results of these
transformations, as well as transformations of pUC19 control DNA, are
depicted in Figure 3.4. The first thing to note about this experiment
is that the concentration of lysate in the transformation reactions is
significantly lower than those performed in Table 2.1 previously and
so detergent associated toxicity effects should be expected to be less
pronounced in turn. Still, there is clearly a dramatic difference
between electroporation efficiencies of lysates. Contrasting the
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chemical transformations in Figure 3.4.A, the autolysis reaction
appears to have been more efficient than the detergent reaction
(either in actual assembly or detrimental effects on transformation)
but the overall colony forming units (CFU) per femtomole appear to be
comparable. However, when looking at the electroporation results there
is a clear effect of detergents which is more succinctly stated in
Figure 3.4.B as fold difference between chemical transformation and
electroporation. It is also interesting that autolysis seems to have a
more pronounced difference in electro- versus chemical transformation
than that of the pUC19 positive control however, the pUC19 controls
may underestimate the fold improvement of electroporation. Typical
efficiencies reported by NEB for their commercially prepared NEB10β
chemicompetent and electrocompetent cells would place the improvement
at roughly ten-fold, matching the observed improvement seen for
autolysis transformation.

3.2. Optimizing the ex vivo DNA assembly reaction
The ‘chew-back, anneal, repair’ end joining mechanism hypothesized to
be the biochemical basis of the ex vivo reaction is an interestingly
complex optimization problem. While exonuclease activity is
imperative, overly active exonuclease activity can destroy the
substrate DNA. Additionally, since dsDNA exonuclease activity cannot
be constrained a competitive polymerization reaction must be
introduced to ‘repair’ uncontrolled exonuclease activity, but not so
much as to undo the requisite ‘chew-back’. Several parameters of the
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ex vivo reaction were empirically investigated for their impact on
this delicate balance.
3.2.1. Reaction Volumes and DNA Concentrations
In its original formulation, ex vivo DNA assembly was performed using
20 µL volumes with 20 ng/µL of the backbone (or larger BCP piece for
linear assemblies) and a 6:1 molar ratio of insert fragments to
backbone piece. While PCR and gel extraction easily generates enough
substrate DNA for a couple reactions, each assembly reaction is
consuming over a full microgram of DNA per reaction. Additionally –
while able to distinguish background colonies by their red coloration,
there was an exceptional amount of red colony formation for gelpurified substrates. To address these issues we made a concerted
effort to not only reduce the DNA required for an ex vivo reaction and
the amount of red background colonies.
First, the background was addressed by looking at our DNA preparation
steps. The bands from our PCR reactions looked very strong and free of
side-product formation yet somehow considerable template plasmid was
co-purified with our backbone amplicon. Looking at our protocol for
PCR we noted that for simplicity we had been adding 1 µL of pure
plasmid mini-prep as template for a 50 µL reaction. Concentrations of
our mini-preps usually range between 50-100 ng/µL for the high-copy
plasmids used by ex vivo DNA assembly. Given that NEB protocols for Q5
DNA polymerase call for a maximum of 1 ng of plasmid template per 50
µL reaction we were adding 50 to over 100 fold excess template DNA
necessary for PCR. In response, working dilutions of template plasmid
41

at 1 ng/µL were prepared and PCR performed in the same fashion.
Resultant gels still showed very bright banding indicative of
successful PCR and eluents from gel extractions contained equivalent
concentrations of DNA. However, assemblies and subsequent showed a
drastic decline in the number of red colonies (~0-2 colonies per
plate).
Next, the concentration of DNA used in a typical reaction was
decreased along with the total volume of each reaction. Instead of a
20 µL volume, 20 ng/µL backbone and a 6:1 insert to backbone molar
ratio, reactions were performed in 10 µL volumes using 5 ng/µL
backbone (50 ng per reaction) and a 1.2:1 (2-way assemblies) or a
2:1.2:1 (3-way assemblies) molar ratio. This increased the number of
reactions capable of being performed per preparation of DNA fragments
by 4-fold (50 versus 200 ng backbone per reaction).
3.2.2. Calculating Protein Concentration
By reducing the DNA substrates used in each reaction and increasing
our lysate concentrations (lysis efficiencies), we found many of
initial reactions degraded most or all of the substrate DNA. The
reduced substrate and increased catalyst concentrations had tipped the
delicate balance between chew-back and repair making it clear
adjustments to the lysate concentration were needed. Unfortunately,
quantifying the “concentration” of the catalysts for ex vivo DNA
assembly poses a challenge. First, the cellular extract is a highly
heterogeneous environment with many species capable of interfering
with quantification. Second, even if the responsible catalysts were
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capable of being specifically quantified their identities still remain
largely unknown. Even so, measures of total protein concentration were
employed as a proxy since the catalysts are almost certainly proteins.
The most common techniques for estimating the concentration of
proteins are based on either a colorimetric reaction (e.g., Lowry56,
Bradford57) or UV absorbance spectrophotometry (absorbance at 280 nm)58.
Deciding on the most appropriate method depends upon multiple factors
including the concentration of protein in the sample, the amino acid
composition of the peptide and the presence of interfering substances
in the sample or buffer. For the ex vivo extracts Bradford
colorimetric assays were compared with simple spectrophotometric
absorbances of 280 nm for aromatic rings of amino acid side chains
(mainly tyrosine and tryptophan), 260 nm for nucleic acids and/or 205
nm for peptide bonds.
Standard curves were generated for Bradford colorimetric assays using
either Bovine serum albumin or lysozyme, at a minimum of three
different quantities (along with blanks) in either water, the CelLytic
detergent or the lysis/storage buffer matching the lysate samples used
in the assay. While the Bradford reaction is typically incompatible
with detergents, we found that the diluted samples still generated an
acceptable standard curve. However, the concentrations of the lysates
predicted by the Bradford (as could be expected) was dependent upon
the protein used to calibrate the standard curve, the time allowed for
color development and even the spectrophotometer used. Additionally,
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the assay requires the purchase of reagents and standards and a fairly
time-consumptive, fickle protocol to measure samples and standards.
The difficulties posed by the Bradford assay prompted a simplified
approach to concentration estimation. Peptide bonds can be detected in
solution using absorbance at 205 nm59, but when tested with lysate the
assay was found to be overly sensitive, inviting error from extensive
dilutions. Protein content can also be estimated using absorbance at
280 nm targeting the aromatic side chains of amino acids such as
tryptophan and tyrosine. The challenge faced in a cellular extract
context is interference from nucleic acids that also absorb in the 280
nm spectra. To correct for the presence of nucleic acids in the lysate
absorbance at 260 nm was measured and a correction applied using the
equation of Warburg and Christian58. While Warburg-Christian method is
also susceptible to interference (e.g., NAD/NADP) it was found to be
rapid, requiring minimal sample manipulation and having high
reproducibility (for one sample diluted and measured in triplicate
standard error of the mean = 0.012 mg/mL).
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Figure 3.5 Concentration of Lysate
Here XJa lysate prepared by autolysis was measured via spectrophotometry and adjusted
by the method of Christian-Warburg. Product Band intensities are calculated relative
to the BCP band of the negative control lane. Gel picture for 60 minutes is in Figure
B.4 and 120 minutes is in Figure B.5.

Applying the Warburg-Christian method to quantify our lysates a 2-way
linear assembly was performed using titrations of autolysis-derived
XJa lysate. Samples were removed at 60 minutes and after a full 120
minutes, visualized and interpreted in Figure 3.5 as the intensity of
the product band. While in the first 60 minutes there is a product
band formation at all tested concentrations, the second 60 minutes
distinctly contribute a large portion of the final bands. This could
be evidence that most of the “repair” activities do in fact precede in
the second half of the 120-minute reaction. However, at higher
concentrations of lysate the product bands produced in the initial 60
minutes are consumed, likely by the additional exonucleases present in
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the reaction. Looking at the results of the gel it would appear that
the optimal final protein concentration of the autolysis lysates is
between 10-50 µg/mL. Since our stocks of lysates produced via
autolysis were measured at ~7-8 mg/mL, a 10X concentration could be
reached by a 1/200 dilution of the lysate.
3.2.3. “Base” Buffer Optimization
In order to function many enzymes rely on the presence of cofactors
and various energy sources. In section 2.2 the effects of Magnesiumto-ATP concentration were investigated and the results revealed an
important relationship between the relative quantities of magnesium
ions and available ATP. Beyond these two components of the reaction
buffer, the other components were not varied but may illicit
improvements in the overall reaction efficiency.
We tested the formulation of the ex vivo DNA assembly buffer with a
few changes to more closely match buffer formulations optimal for
purified E. coli enzymes, in particular for the E. coli DNA ligase
(Eco Ligase). For all buffers tested the NAD+ was reduced to 50 µM
(typically 26 µM for Eco Ligase) and Bovine Serum Albumin (BSA) at 50
µg/mL. Further the Magnesium and ATP levels were, once again, titrated
between 4 mM Magnesium and 50 µM ATP.
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Figure 3.6 Optimization of components of “Base” Buffer
The components of the base buffer were varied between their original values and values
commonly used for the buffers of various molecular biology enzymatic reactions. Fold
difference represents the change in product band intensity of the sample as compared to
“+” sample of the same lysate type. Band intensities are calculated relative to the BCP
band of the negative control lane. Original gel pictures are shown in Figure B.6 and
Figure B.7.

The NEB10β prepared by detergent lysis showed decreasing efficiencies
with the decrease in NAD+ and addition of BSA when compared to the
standard buffer. In contrast, the autolysis XJa showed a slight
47

increase in assembly efficiency with the addition of BSA and decrease
in NAD+. In fact, XJa showed an increase in all tested conditions over
the standard buffer. Unfortunately, without additional replicates it
is unclear whether the observed trend is due to differences in the XJa
autolysis lysate versus the NEB10β detergent lysate or a function of
fluctuations in the standard lane.
3.2.4. Divalent Metals Titrations
Throughout biochemistry metal ions play an integral role as enzymatic
cofactors. In fact, it has been estimated that metal ion cofactors are
needed in nearly one-third of enzyme-catalyzed reactions60. Most often
these metals are coordinated within the active site of enzymes where
they mediate redox (and sometimes non-redox) reactions by increasing
the electrophilicity of the active site. Once a ligand is bound in the
active site, the metal can act to remove electron density and cause
polarization of reactive bonds in the ligand - usually C-O or P-O in
nature61.
As the most abundant divalent metal species in cellular contexts,
magnesium is the most frequently utilized metal in active sites. As
discussed previously, in physiologic environments magnesium forms
stable chelates with molecules containing phosphate such as ATP, RNA,
DNA and other nucleic acids. The tendency of magnesium to maintain
elevated hydration states is the primary means by which it acts as a
cofactor to bind and catalyze nucleic acid substrates61.
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Due to its poor spectroscopic and crystallographic properties
researchers have long employed other divalent metal analogues to study
nucleic acid enzymology. While analogues such as zinc, calcium and
most often manganese are acceptable for structural studies, these
metals often display differing biochemistries to magnesium62. In fact,
it is often observed that other transition metals, especially
manganese, coordinate more tightly with active sites and thereby
confer higher levels of activity. In other instances, the alternate
metal can change the coordination geometry or structural conformation
of the active site altering the substrate specificity, mode of action
or completely inhibiting the protein.
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Figure 3.7 Titrations of Divalent Metal Cations
This figure shows the titration of Zinc Chloride, Manganese Chloride and Calcium
Chloride with Magnesium Chloride and without Magnesium Chloride. Fold difference
represents the change in product band intensity of the sample as compared to “+”
sample (10 mM Magnesium) of the same lysate type. Band intensities are calculated
relative to the BCP band of the negative control lane. Original gel pictures are shown
in Figure B.8, Figure B.9 and Figure B.10. NEB10β is the average of duplicate
experiments and error bars represent standard error of the mean (N=2).

Previously, we established that the ratio of Magnesium-to-ATP in the
ex vivo DNA assembly buffer was crucial for efficient end joining,
most likely as a consequence of ATP’s ability to chelate magnesium and
the resulting effects on RecBCD activity. Although magnesium dominates
as the native cofactor for nucleic acid-directed enzymes, we decided
to test the effects of titrating zinc, manganese and calcium on the
efficiency of end joining.
Using XJa (autolysis) and NEB10β (detergent) four formulations of each
metal were tested with respect to magnesium (mM:mM): 1:10, 10:10, 1:0,
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10:0. The results of this 2-way linear titration depicted in Figure
3.7 are compared to a control reaction with the ex vivo DNA assembly
“base” buffer. Just as in the “base” buffer optimization in 3.2.3
there are clearly differing trends seen for the NEB10β/detergent and
the XJa/autolysis lysates – although there is also some agreement
between the two, as well. Both lysates responded negatively to Zinc in
the complete absence of magnesium, while both responded positively to
the addition of manganese – even in the complete absence of magnesium.
XJa actually shows an increase in efficiency across all tested
conditions so long as 10 mM of magnesium was present. Perhaps more
surprising is that for both manganese and calcium XJa showed
equivalent or higher activity even in the absence of magnesium. On the
other hand, outside of manganese NEB10β clearly did not tolerate the
omission of magnesium. The extremely pronounced response to manganese
by both lysates prompted further investigation into the
supplementation of manganese to the standard ex vivo DNA assembly
buffer.
3.2.5. Manganese
The strong activation of DNA assembly imparted by manganese in the
titrations of the previous section (3.2.4) prompted a more detailed
study of manganese. Using a similar titration approach between
magnesium and manganese, 2-way linear assemblies were performed using
NEB10β lysate. Again, Figure 3.8 shows a comparison of the titrated
samples relative to the intensity of the product band formed by the
basic ex vivo DNA assembly buffer containing 10 mM magnesium and 0 mM
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manganese. In the experiment, total divalent species were held at 1011 mM with the exception of the 0:2 and 0:6 magnesium:manganese
(mM:mM) samples. In Figure 3.9, the results are displayed again, but
showing the compositions of the lane by band (product band; BCP and
Promoter substrate bands and; degradation band of lowest molecular
weight) relative to the BCP band of the negative control lane (-).
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Figure 3.8 Titrations of Magnesium and Manganese
Using NEB10β lysate and the 2WL assembly, magnesium and manganese levels were titrated
against one another. The ratio labels indicate the concentration of magnesium chloride
(mM) to manganese chloride (mM) with the 10:0 ratio representing the original buffer
constitution (+). Fold difference represents the change in product band intensity of
the sample as compared to “+” sample of the same lysate type. Band intensities are
calculated relative to the BCP band of the negative control lane. Original gel picture
is shown in Figure B.11.
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Figure 3.9 Lane composition of Manganese to Magnesium Titration
Chart shows the relative intensities of the product (Blue), BCP (Red) and Promoter
(Green) substrate bands, as well as the low molecular weight band representing
degradation products (Purple). Columns are displayed inverted to more closely
represent the actual gel and the order in which the bands migrate. Band intensities
are calculated relative to the BCP band of the negative control lane. Original gel
pictures are shown in Figure B.11.

The results of the 2-way assembly – albeit less pronounced - confirm
the observed increase in assembly efficiencies previously observed in
the metal titration experiment. The ratio of magnesium to manganese
appeared to have minimal impact. In fact, even the 0:10 sample was
able to catalyze assembly with at least equal efficiency to that of
the positive control. Visualizing the lane compositions in Figure 3.9
provides more details into the possible mechanisms by which manganese
may be enhancing assembly. For instance, the largest consumption of
substrate DNA did not directly correlate with product formation as
there was more remaining substrate DNA in the higher manganese ratio
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lanes containing the highest level of product. Further, both lanes
containing 10 mM manganese (1:10 and 0:10) appear to have the most
total DNA in the lane overall. This phenomenon is more than likely
attributed to increased DNA polymerase activity in the presence of
manganese. Indeed, the literature is ripe with evidence showing that
in the presence of manganese DNA polymerases (including the E. coli
PolA polymerase) experience a decrease in specificity of base
incorporation as well as 3’-5’ proofreading functions. Such a decrease
in specificity may increase the polymerase activities not only to gapfill the product fragment, but also the chew-backed, partially
degraded substrate bands thereby preserving them.
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Figure 3.10 Effect of Manganese on Two-way Circular Assembly
Using XJa lysed with either CelLytic or using freeze-thaw autolysis, circular
assemblies were performed in the original buffer (- Mn) or with the addition of 1 mM
Manganese Chloride (10:1 ratio). Percentages represent Blue colonies to all colonies
(blue and white). Error bars represent standard error of the mean for reactions
performed in duplicate (N=2).

If the presence of the manganese is mutagenizing the recombined
product then its addition – regardless of the improvements in apparent
end joining – are undesirable for cloning. However, the 2-way linear
assay has no way of revealing incorporated mutations. To reveal any
increases in mutation rates as a result of manganese supplementation
shows the results of 2-way circular assemblies with and without 1 mM
manganese. The results still show an increase in total colonies formed
across all lysates, but an increase in mutation rate is not
immediately apparent. This does not necessarily mean there is not an
increase in mutation rate from the addition of magnesium, because the
number of white colonies falls outside the countable threshold (<30
CFU per plate) for XJa autolysis and NEB10β. For the XJa detergent
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sample that did have a countable number of white colonies there was a
decrease in percentage of correct colonies.
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Chapter 4. Probing ex vivo DNA Assembly
with Enzymatic Titrations
The absence of the cell membrane allowed rapid prototyping of buffer
compositions, substrate and catalyst concentrations, and titrations of
small molecules. To uncover biochemical mechanisms typically enzymes
are purified and titrated together in an in vitro study or knockedout/overexpressed in an in vivo study. Both of these approaches can be
leveraged in ex vivo experimentation to uncover underlying phenomena
of the larger system.

4.1. Enzymatic Titrations
Tapping into the wealth of commercially purified cloning enzymes
already available through molecular biology suppliers, the underlying
biochemistry of ex vivo DNA assembly was probed using enzymatic
titrations. Building on the premise that the ex vivo DNA assembly
reaction proceeds via a chew-back, anneal and repair pathway similar
to Gibson assembly, we purchased available exonucleases, polymerases
and ligases (as well as RecA, a homologous recombination protein)
native to E. coli. Table 3.1 gives details about each enzyme used in
the titration experiment.
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Table 4.1 Enzymes used in Titration
E. coli gene

Function

Product(s)

Exonuclease III

xthA

3' to 5' dsDNA
exonuclease

ssDNA and dNMP

RecJf

recJ

5' to 3' ssDNA
exonuclease

dNMP

Exonuclease I

xonA/sbcB

3' to 5' ssDNA
exonuclease

dNMP and
dinucleotide

Exonuclease T

exoT

3' to 5' ssDNA and
RNA exonuclease

dNMP

Exonuclease V
(RecBCD)

recBCD

dsDNA processive
endonuclease

short oligos

E. coli DNA Ligase

ligA

DNA ligase

phosphodiester
bonded DNA

DNA PolI

polA

DNA polymerase

DNA polymer

RecA

recA

ssDNA binding
protein

N/A

The addition of exonucleases can help elucidate the possible overhangs
generated from chew-back. For example, if homologous overhangs were
generated as 5’ overhangs, it would be expected that supplementing
RecJf would greatly decrease assembly efficiencies, as the homologous
regions are substrates for degradation by RecJ. The three nonnucleases – E. coli Ligase, Polymerase I and RecA – are supplemented
to see if they address a bottleneck or inefficiency.
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Figure 4.1 Titrations of Various DNA cloning Enzymes
The results of titratons of various purified enzymes in XJa lysates are shown. The bar
colors reflect concentration of enzyme with blue, red and green reflecting the
concentrations lowest to highest. Red represents units necessary to catalyze the
formation of 10 nmol of product in a 20 µL reaction – except for RecA which had no
unit definition. Unit definitions are available in Table A.4. Units were added as
follows: RecBCD (.05, .2, .4); PolI (.1, .4, 1); RecA (2, 8, 20 µg); Eco Ligase (.1,
.4, 1); ExoI (.1, .4, .8); ExoIII (1, 4, 10); ExoT (5, 20, 50); RecJ (30, 120, 300).
Fold difference represents the change in product band intensity of the sample as
compared to “+” sample (no enzyme). Band intensities are calculated relative to the
BCP band of the negative control lane. Original gel pictures are shown in Figure B.12
and Figure B.13.

To determine relevant concentrations for each enzyme, the unit
definitions provided by NEB were employed to calculate the number of
units necessary to catalyze the formation of 10 nmol of product in a
20 µL reaction volume (5 ng/µL BCP is approximately 11 nmol). These
values were used as a baseline to select three concentrations of each
enzyme to test in conjunction with a 2-way linear assembly.
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Results of the assembly shown in Figure 4.1 were unexpected for
several reasons. The most glaring outcome is the stimulating effect of
ExoI and ExoT on assembly. It was not expected that any of the
exonucleases would improve assembly as this has not presented as a
rate-limiting step and can be a substrate sink if homologous ends are
consumed. Clearly, for the 3'→5' ssDNA exonucleases ExoI and ExoT (at
low quantities) the homologous overhangs are not being consumed. This
is made clearer by Figure 4.2, which shows the lane composition of the
titration. By looking at the lane composition and status of the
substrate DNA, the activities of the various enzymes become clearer.
For instance, it is very clear that the lack of product formation in
the dsDNA exonuclease lanes is a direct result of consuming the
substrate DNA. In contrast, RecJ appears inefficient at assembly not
because it is consuming the substrate DNA, but for some other reason.
It is very possible that the homologous overhangs produced during the
ex vivo DNA assembly are 5’ extensions. These extensions would be
compatible substrates for degradation by RecJ resulting in a loss of
the necessary homology and the creation of inert substrate DNA.
However, it is also important to realize that these graphs are still
numerical interpretations of the gel results. In the case of ExoT,
without looking at the gel picture (Figure B.13) it would be nearly
impossible to observe the decreasing resolution and molecular weight
of the product band due to extensive degradation.
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Figure 4.2 Lane Composition of Enzymatic Titration
Chart shows the relative intensities of the product (Blue), BCP (Red) and Promoter
(Green) substrate bands, as well as the low molecular weight band representing
degradation products (Purple). Columns are displayed inverted to more closely
represent the actual gel and the order in which the bands migrate. Band intensities
are calculated relative to the BCP band of the negative control lane. Original gel
pictures are shown in Figure B.12 and Figure B.13.

In the non-exonuclease category, improvements were observed using E.
coli DNA ligase and RecA while addition of the DNA polymerase I
inhibited assembly. Looking at the composition of the PolI lane the
substrate fragments are maintained. The PolI protein has dual
exonuclease activities: a 3'→5' proofreading activity typical of DNA
polymerases and a 5'→3' exonuclease activity most likely used for nick
translation. Similar to RecJ, the presence of substrate DNA and known
5'→3' activities suggests that PolI may be consuming the homology of
the overhangs.
61

4.2. RecA Titrations
Improvements in end joining in the presence of RecA was surprising as
previous investigation revealed that recA+ strains of E. coli are
suboptimal for ex vivo DNA assembly. RecA is a highly multifunctional
protein in vivo, acting as an ssDNA binding protein63, catalyzing
strand exchange64 and even acting as a highly specific protease (of the
LexA protein) to signal the host SOS response to DNA damage65,66.
Mechanistically, RecA performs its DNA recombination functions by
binding tightly to ssDNA in long nucleoprotein filaments. Once bound
to a ssDNA substrate (and ATP) RecA’s secondary DNA binding site will
bind to a dsDNA polymer and begin a “homology search” scanning across
the dsDNA substrate for sequence matching the ssDNA. Once found, the
RecA nucleoprotein filament can catalyze strand exchange and the
formation of an intermediary triplex DNA64. Given the unique
contradiction seen between in vivo produced RecA and ex vivo
supplemented RecA further titration experiments were performed. Using
the 2-way linear assembly, Figure 4.3 and Figure 4.4 show the results
of RecA supplementation in a 20 µL reaction using XJa autolysis
lysate.
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Figure 4.3 Titrations of RecA
RecA protein was added to an XJa lysate in a 2-way linear assembly. Fold difference
represents the change in product band intensity of the sample as compared to “+”
sample (no enzyme). Band intensities are calculated relative to the BCP band of the
negative control lane. Original gel picture is shown in Figure B.14

The repeated RecA titration showed a similar trend to that observed in
the initial titration as additional RecA facilitates end joining in
the two-way linear assembly. Although, it would appear that at a
certain point the concentration of RecA becomes saturating – possibly
even reducing assembly efficiency (as in Figure 4.1). The normal
function of RecA to recombine ssDNA with a dsDNA substrate is not the
same single-strand annealing method proposed earlier, but is clearly
aiding in assembly. Again, looking at the lane compositions in Figure
4.4 it would appear that RecA helps to protect the substrate DNA from
degradation as the total band intensity of the RecA lanes exceed that
of the positive control lane.
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Figure 4.4 Lane composition of RecA titration
Chart shows the relative intensities of the product (Blue), BCP (Red) and Promoter
(Green) substrate bands, as well as the low molecular weight band representing
degradation products (Purple). Columns are displayed inverted to more closely
represent the actual gel and the order in which the bands migrate. Band intensities
are calculated relative to the BCP band of the negative control lane. Original gel
pictures are shown in Figure B.12 and Figure B.13.

Finally, RecA was supplemented to 2-way circular assemblies,
transformed and the resulting colony counts compiled into Figure 4.5.
It would appear that there is another dynamic happening here – either
during circularization or transformation – which decreases the
efficiency of assembly for the circular assembly. Moreover, with
“homology search” functions of RecA it was disappointing to find that
RecA contributed nothing toward improving the mutation rate of
assembly either.
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Figure 4.5 Colony counts of exDA reactions containing RecA
Assemblies were performed using basic buffer or supplemented 200 ng RecA using
autolysed XJa or XJa lysed with detergents. Percentages represent Blue colonies to all
colonies (blue and white). Error bars represent standard error of the mean for
reactions performed in duplicate (N=2).

4.3. Strain Engineering (nuc4- and autolysis cassette)
Just as previously purified enzymes can be supplemented to the ex vivo
reaction to synthetically test the effects of increased protein
concentration, the genetic background of the strain can be altered to
knockout the expression of native enzymes. Strain engineering or
‘recombineering’ (short for recombination-mediated genetic
engineering) uses transformed DNA with homology to the host genome in
order to target and integrate changes into the chromosome67. In E. coli
this can be accomplished by the Lambda Red operon of bacteriophage
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lambda68. This three-protein operon encodes a 5’-to-3’ exonuclease
(alpha), a single-strand annealing protein (beta) and a protein, which
binds and inhibits RecBCD activity (gamma). For both the native
bacteriophage’s linear dsDNA genome or transformed ds/ssDNA the Lambda
Red system works by inhibiting RecBCD (preventing degradation of
substrate DNA), converting the dsDNA to a fully single-stranded
intermediate and annealing the subsequent ssDNA to homologous regions
of the genome exposed as ssDNA during DNA replication69,70. Genomic
changes can be selected if the targeting DNA integrates a selectable
marker cassette (i.e., antibiotic resistance), otherwise colonies must
be plated and screened via a high-throughput genotyping method like
allele-specific PCR71,72.
Given the promising applications of genome engineering considerable
effort has been invested in optimizing Lambda Red and other
methodologies (e.g., homologous recombination, RecET, CRISPR-Cas)15,67,7376

. The Church group pioneered a Lambda Red recombineering method to

make many changes across the genome in an automated fashion known as
‘Multiplex Automated Genome Engineering’ (MAGE) using a closed-loop
device to grow/recover cells, induce Lambda Red from a heat-inducible
operon on the E. coli genome, and transform a solution of editing
oligonucleotides77-79. In an effort to optimize MAGE this same group
employed MAGE to knockout the most active E. coli ssDNA exonucleases
(RecJ, ExoI, ExoVII and ExoX) creating a strain known as nuc4(Genotype in Table A.2 and Table A.3), which they subsequently
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deposited into the Addgene repository (Addgene bacterial strain
#40803)80.
We acquired the nuc4- strain from Addgene in order to test its
suitability as a strain for ex vivo DNA assembly with the underlying
assumption being that these exonucleases may compete to degrade
exposed homologies. Since this strain contained the Lambda Red system
we decided to integrate the lysis cassette from the XJa strain to
create and autolysis version of the nuc4-, which we dubbed nuc4-.λR
(for Genotype and description see Table A.2 and Table A.3; for oligo
sequences see Table C.3).
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Figure 4.6 ex vivo DNA Assembly with nuc4-.λR and Lambda RED
Assemblies were performed using original buffer, supplemented with 1 mM Manganese or
200 ng RecA using autolysed nuc4-, nuc4- with λ Red or XJa. Percentages represent Blue
colonies to all colonies (blue and white). Error bars represent standard error of the
mean for reactions performed in duplicate (N=2).

Once isolated, the nuc4-.λR strain was used to create two lysates. One
lysate was prepared by the same methods as XJa (-λRED), while the
other was heat-shocked to induce production of the Lambda Red proteins
(+λRED) as other studies have shown the Lambda RED system capable of
facilitating DNA assembly13,81. The resulting lysates were used to
perform 2-way assemblies with the standard buffer, with Manganese and
with RecA (Figure 4.6). We were disappointed to find that our nuc4-.λR
showed no improvement over the standard XJa reaction under any tested
conditions with or without the inclusion of the Lambda RED system.
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Unfortunately, it is impossible to infer the direct relationship
between the genotypic changes in nuc4-.λR and their impact on DNA
assembly due to the absence of proper control strains. To clarify, we
saw in the enzyme titration (Figure 4.1) that ssDNA exonucleases can
have strong stimulating or inhibitory impact on DNA assembly. nuc4-.λR
has four ssDNA exonucleases knockout, including one shown to stimulate
DNA assembly (ExoI) and one shown to inhibit it (RecJ) in the enzyme
titration experiments. Moreover, the parental strain (E. coli MG1655)
that nuc4-.λR is derived from does not have the mutations in endA and
recA like the cloning strains used throughout this study. While MAGE
oligonucleotides were purchased to disrupt endA and recA via Lambda
RED recombineering (sequences in Table C.3), we were never able to
identify clones containing the mutant alleles. Without progressive
knockouts of the ssDNA exonucleases with background mutations in the
recA and endA loci to use as controls it is impossible to make direct
conclusions about the effect of each knockout as it pertains to DNA
assembly.
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Chapter 5. ex vivo PCR and ex vivo Cloning
5.1. The pUN plasmid and ex vivo PCR
Using lysates derived from completely “wild-type” strains it is
possible to perform sophisticated in vitro reactions such as protein
expression or DNA assembly. As demonstrated in the previous section,
the background genotype of the E. coli can be easily manipulated using
modern genome editing tools to investigate genotype-phenotype
relationships or create strains with phenotypic enhancements (i.e.,
autolysis). In a similar but perhaps simpler manner, expressional
plasmids can be constructed and transformed into existing strains to
produce one or more proteins (or even mRNA). Plasmid-based expression
allows rapid introduction into the various strain backgrounds without
the challenges required to integrate cassettes into the genome. We
refer to lysates containing an (over)expressed protein(s) as a
‘functionalized lysate’, as a novel function has been imparted to the
lysate. The following chapter demonstrates a functionalized lysate
containing the Pyrococcus furiosus (Pfu) DNA polymerase that has the
newly imparted ability to perform PCR. This functionalized lysate is
then applied to amplify the fragments for 2- and 3-way assemblies,
which are subsequently assembled and transformed using our ex vivo DNA
assembly approach.
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5.1.1. Design and construction of the pUN plasmid
Many plasmids have been developed and are available through numerous
for- and not-for-profit distributors. These plasmids usually have
features associated with specialized purposes such as clonal
amplification, protein expression, interspecies transfer or phage
production. Traditionally features are included which facilitate
cloning/DNA assembly such as multiple cloning sites, integrase sites
(Gateway cloning) or counter-selectable markers82.
Up to this point, ex vivo assembly and its assays employed the
commonly used high-copy number Biobrick plasmids, pSB1C3 and pSB1K3 to
conduct assembly assays. These plasmids are freely distributed under a
creative commons license and are fully compatible with the ‘Biobrick
AssemblyTM cloning methodology. However, we decided to design and
develop our own vector useful for expression and cloning via ex vivo
DNA assembly and other sequence-independent cloning methods.
The plasmid backbone was derived from the pJ251-GERC vector available
in the Addgene repository (Addgene plasmid #47441)83. The backbone
fragment (amplified by pGERC_BB-f/-r; see Table C.2) contains the
Kanamycin resistance selectable marker and the low copy number p15a
origin of replication (~5-10 copies per cell). The second-half,
‘insert’ portion was synthesized as two linear fragments by Integrated
DNA Technologies (IDT) and contains all the designed cloning and
expressional features. The ‘insert’ design draws heavily upon the
“Unique Neutral Sites” (UNS) developed by Torella, et al84. A UNS is a
computationally derived 40 base pair site that meets several design
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criteria including: approximately 50% GC-content without homopolymeric
runs; Unfavorable intramolecular (hairpins) and intermolecular
(bonding between different UNSs) interactions; absence of common
restriction/cloning sites; absence of start codons, promoter-like
sequences or sequence homology to the E. coli MG1655 genome. The
authors reported 10 UNSs that were subsequently demonstrated to
assemble multiple repeated sequences via Gibson assembly and even
provided functional insulation of promoter sequences from genetic
context. In our design, some of these UNSs are incorporated throughout
the insert separating each of the following features (in order from 5’
to 3’): an upstream terminator; a T5 promoter and 5’ untranslated
region with a ribozyme; a newly optimized BCP cassette driven by a
strong constitutive promoter and synthetic ribosome-binding site (RBS)
and; two strong downstream terminators (sequence available in C.2.6).
The design of the insert was such that the new BCP cassette can be
replaced with a desired RBS and protein coding sequence (CDS) and be
driven by the strong upstream T5 promoter. Since the original BCP
insert causes a very strong (and quicker developing) blue
pigmentation, assemblies can be screened for the presence of
background colonies. Unfortunately, we have found that the upstream
promoter does not transcribe through the downstream UNS site so
currently a promoter needs to be included with expression assemblies.
However, it is from the UNS sites that our plasmid derives its
namesake, pUN (for “plasmid unique neutral”). The embedded UNS sites
play a critical role not just for simplifying assembly and insulating
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parts as demonstrated by the original authors, but as ideal priming
sites for PCR. For all the reasons the UNS sites make excellent
termini for assembly reactions, these sites are also ideal primer
sequences for amplification or as 5’ embedded overhangs. Indeed, we
designed and synthesized forward and reverse primers for each UNS site
(sequences available in Table C.2) and have performed PCR from all
incorporated UNS sites without any preliminary optimization or
troubleshooting.
5.1.2. Construction of pUN-PrhaBAD-Pfu
In Addgene there are two DNA polymerase-expressing vectors available:
pAKTaq (Addgene plasmid #25712) that expresses the Thermus aquaticus
(Taq) DNA polymerase and pET16b.Pfu (Addgene plasmid #12509) that
expresses the Pfu DNA polymerase. While we were able to successful
express the Taq protein and use it to perform ex vivo PCR, Taq is a
less than ideal cloning polymerase. Taq does not create flush termini
(leaves one 3’ adenine residue overhang) and also lacks the
proofreading activities typical of high-fidelity polymerases. On the
other hand, Pfu has proofreading abilities and creates blunt-ended
products ideal for cloning purposes, but the pET16b.Pfu construct is a
nightmare for E. coli expression. The difficulty stems from the poor
codon compatibility of the Pfu coding sequence with E. coli as the
host. To circumvent the poor codon adaption a special strain of E.
coli (BL21(DE3) Rosetta) is needed which hosts a vector overexpressing
some of the less prevalent tRNAs along with the DE3 prophage (for T7
polymerase expression).
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In the spirit of open-access ex vivo DNA assembly we decided it was
prudent to have the coding sequence codon optimized and synthesized so
that the Pfu gene can be expressed in any E. coli. To perform codonoptimization the COOL codon optimization tool (http://bioinfo.bti.astar.edu.sg/COOL/) was employed to simultaneously maximize codon
context and codon adaptability for E. coli85. With the Ribosome Binding
Site Calculator tool a synthetic ribosome-binding site was designed
based on the codon-optimized Pfu gene and an upstream wild-type
rhamnose-inducible promoter (PrhaBAD)9,86. The resulting cassette plus
the flanking UNS sequences was synthesized by IDT as two overlapping
fragments of 1144 and 1483 base pairs and subsequently assembled along
with the backbone using ex vivo DNA assembly. Of the approximately 200
white transformants, 24 colonies were lifted (along with two blue
colony controls) and used as template in colony PCR. The PCR amplified
from UNSX across the entirety of the Pfu cassette to UNS9, and of the
24 clones all 24 showed amplicons at the expected size (~2800 bp; Blue
colonies were ~1500) although the bands were faint. Of these 24, 3
clones were miniprepped the next day and sent for sequencing (Eurofins
MWG). Of these three, one clone was identified as completely correct
and used for subsequent procedures (pUN-PrhaBAD-Pfu sequence available
C.2.7).
5.1.3. Expression and Preparation of ex vivo PCR lysate
As the original plasmid was transformed into NEB10β (and XJa/autolysis
strains are a rarity in labs), expression and lysis was performed in
NEB10β for all subsequent steps. Expression was performed by
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inoculating 24 mL of pre-warmed SOB media (in a 125 mL Erlenmeyer)
with 200 µL of an overnight culture, allowing growth for approximately
2 hours, then adding filter sterilized 20% w/v rhamnose to a final
concentration of 0.2% (~250 µL).
To assay the culture for the production of the Pfu DNA polymerase,
aliquots were removed at 6, 9 and 24 hours post-induction and frozen
until needed. The remainder of the culture was collected at 24 hours
post-induction. These aliquots were lysed using CelLytic B, diluted
and protein content quantified by Bradford assay. Each protein sample
was prepared with 25 µg of total protein (along with a NEB10β negative
control) and visualized using SDS-PAGE under denaturing conditions. In
the resultant gel (Figure 5.1) there is clearly a strong band in all
the sample lanes at roughly 90 kD that is absent in the negative
control lanes. This size correlates with the predicted molecular
weight of the Pfu DNA polymerase (90.11 kD). Interestingly, there
appears to be little variation in the concentration of Pfu across the
different harvesting times.
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Figure 5.1 Expression of Pfu DNA
Polymerase
Soluble lysate of NEB10β expressing Pfu was
harvested at different time points and
separated via denaturing SDS-PAGE. “C” is
NEB10β without pUN plasmid, “L” is lowmolecular weight ladder.

Given the encouraging results of the protein gel in Figure 5.1, the
remaining pellets of the culture harvested at 24 hours were thawed and
used to prepare lysates for ex vivo PCR. The lysis reaction was
performed using CelLytic B in a 1.5:1 ratio and incubated at 30°C for
15 minutes and subsequently diluted with lysis buffer to a final
volume-to-pellet mass ratio of 5:1. While most of the lysate was
centrifuged to remove the cellular debris an aliquot was first removed
which retained the total cellular extract. The soluble fraction and
the total cellular extract were next incubated at 80°C for 30 minutes
to kill any host proteins (such as nucleases). The lysates are given
one last extended spin in the centrifuge to pellet any denatured
insoluble host proteins and the supernatant aspirated and diluted by
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half with 100% glycerol. As with the ex vivo DNA assembly lysates,
these lysates are stored at -20°C and can be safely removed and
replaced into the freezer many times.

Figure 5.2 Volumetric titrations of ex vivo PCR
Functionalized lysates of Pfu were titrated to amplify the BCP band used in 2-way
linear assemblies. Bands to the right were prepared with total lysate in the heat-kill
process. The values below the bands indicate µL of lysate used per 50 µL reaction; “C”
represents negative control of purified BCP fragment.

5.1.4. ex vivo PCR
Equipped with lysates containing the Pfu DNA polymerase, initial PCR
reactions amplifying the 2-way circular BCP fragment were formulated
using volumetric titrations of the extracts in a standard 50 µL Pfu
PCR reaction. These titrations shown in Figure 5.2 exhibit a very nice
trend with a peak at 1-2 µL of cell extract per 50 µL PCR. Comparing
the bands on the left (heat-killed soluble fraction only) to the bands
on the right (heat-killed total extract) it would appear that
including the total cellular extract in the heat-kill step of lysate
preparation increases the yield of Pfu in the final extract. This may
be due to additional lysis of cells surviving the detergent treatment
or may occur by freeing Pfu trapped in the insoluble fraction of the
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extract prior to centrifugation. Second, it is clear that using
excessive extract (or too little) causes an observable decrease in PCR
efficiency. It is therefore advisable to perform a small titration
experiment each time new lysates are prepared. While a slightly
inconvenient consumption of materials and time, the long-term savings
from the ex vivo approach are more than worth the investment.

Figure 5.3 ex vivo PCR of 2-way and 3-way Fragments
Fragments for 2-way circular (2WC), 2-way linear (2WL) and 3-way circular (3W) were
amplified using ex vivo PCR. In addition control PCRs were performed to detect the
contribution of background genomic (BG 16S) and pUN-PrhaBAD-Pfu plasmid (pUN) DNA. The
positive background (+ pUN) control had purified plasmid template added. There is a
clear presence of background amplification and side amplification (see BCP lanes).

After constructing our Pfu-functionalized lysate and prototyping the
ex vivo PCR reaction with volumetric titrations, ex vivo PCR was
applied to generate the substrate DNA for 2-way linear, 2-way circular
and 3-way circular assemblies. The analytical gels shown in Figure 5.3
demonstrate that Pfu-functionalized lysate was capable of synthesizing
all the substrate DNA used in our assembly assays we decent
efficiency. However, there is a fair amount of side-product formed in
some of the reactions. The presence of high levels of contaminating
host DNA may be the critical factor in the side-product formed. This
is clearly evidenced by the strong amplicons formed in the background
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control lanes (“BG”). These lanes consisted of ex vivo PCR reactions
using primers targeting the highly conserved 16S genomic loci (“16S”)
or the pUN-PrhaBAD-Pfu (“pUN”) plasmid but without the addition of
template. In the future the steps to remove host DNA contaminations
would bolster ex vivo PCR fidelity. Fortunately, since the Pfu enzyme
is thermostable, non-thermostable nucleases – such as DNase I or
RecBCD – could be used during lysate preparation to destroy host DNA
and then semi-selectively denature by a heat-kill before desired DNA
substrates or products are introduced to the lysate.

5.2. ex vivo Cloning
Up to this point ex vivo DNA assembly has been demonstrated,
investigated and optimized; tools such as clever assays for DNA
assembly, self-lysing strains and a novel cloning plasmid were
designed and developed; and the Pfu DNA polymerase was optimized,
cloned and expressed to functionalize lysates with the ability to
perform a high-fidelity polymerase chain reaction. Yet, the ultimate
objective of the project was to merge these ex vivo tools and
techniques into an encompassing ex vivo-based cloning suite. As with
all cloning, this began with the generation and isolation of substrate
DNA as the remainder of the 2-way and 3-way ex vivo PCRs from Figure
5.3 were purified by gel extraction. Subsequent ex vivo DNA assembly
reactions were performed using our NEB10β detergent-based, XJa
detergent-based and XJa autolysis-based lysates, with the basic ex
vivo DNA assembly reaction buffer or with 1 mM Manganese supplemented.
In-house formulated Gibson mastermix was used as a positive control
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and transformation of substrate DNA (‘TAR’) was used as a negative
control for background assembly.
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Figure 5.4 ex vivo Cloning
Substrate DNA amplified using ex vivo PCR was gel purified and used in ex vivo DNA
reactions. 2 µL of the 10 µL reactions were transformed using in-house prepared
chemicompetent NEB10β. Gibson lane represents a positive control using Gibson
isothermal assembly formulated in-house. TAR is a negative control consisting off DNA
fragments transformed directly into NEB10β without assembly reaction. Percentages
represent Blue colonies to all colonies (blue and white). Error bars represent
standard error of the mean for reactions performed in triplicate (N=3).

The most striking aspect of the ex vivo Cloning pipeline is the
elevated mutagenic rate in comparison with assemblies using Q5 DNA
polymerase (Figure 3.4). While the total (Blue and White) colony
forming units per femtomole are very comparable, the percentage of
white colonies-to-blue colonies changes by over 20% in some
circumstances. Even the Gibson assembly control shows a greatly
increased error rate over typical efficiency. As the only difference
80

between these two tests are the manner by which the substrate DNA was
prepared, it is convincing that the mutations are introduced during
the PCR amplification of the substrates. However, this may not be
indicative of significantly lowered fidelity of Pfu in comparison with
Q5 polymerase, as misamplification products were observed in the ex
vivo PCR reaction (Figure 5.3). Since the primers encode all the
homology necessary for faithful assembly efficiencies of joining
correct amplicons versus misamplified products would be approximately
equivalent. If indeed this is the case, a simple post-lysis digestion
using a non-thermostable nuclease (e.g.,DNase I) followed by the
typical 80°C heat-treatment should alleviate the observed mutational
rate of ex vivo Cloning.
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Chapter 6. Conclusion and Future Directions
Responding to the needs of the synthetic biology community for
inexpensive, rapid and efficient DNA manipulation we were able to
uncover a unique approach to DNA assembly. Working on the observation
that all of the enzymes used in prototypical in vitro manipulations of
DNA are highly conserved, we incorporated an ex vivo approach to
screen several candidate organisms for DNA assembly functions. To
accomplish this we designed a very clever assay of DNA assembly.
Our circular assemblies provided a colorimetric output that allowed us
to interpret the origins of each resulting transformant. In our intial
pilot studies, we used two chloramphenicol plasmids in our two-way
assembly and observed the growth of blue (correct), white (background)
and red (colonies) – with many background colonies observable (Figure
1.1.B). While we realized that this would allow us to track
transformation efficiencies by observing fluctuations in background,
it was not until subsequent studies did we realize that if the donor
plasmids were maintained on different antibiotics than the destination
vector (like in the original 3-way assembly; see Figure 2.3), we could
track mutational rates. Because our assemblies join the BCP coding
sequence to the destination vector at a crucial junction for proper
expression of the BCP protein (across Ribosome Binding Site and Start
Codon), there is a low tolerance for error during end joining. Due to
the low throughput of performing transformation to assess DNA assembly
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(~28 hours) we also designed a linear assembly assessed by gel
electrophoresis (~3 hours) that greatly expanded our investigative
capacities.
We leveraged this linear assembly to optimize and investigate ex vivo
DNA further. During our titration of the assembly reaction with
divalent metals we found contradictory results between our autolysis
strain and detergent lysed strain. This could be a function of the
composition of the detergent, as it could very well contain the strong
chelators EDTA or EGTA in order to improve lysis efficieny. The
presence of these chelators would alter the apparent divalent cation
ratios between detergent and autolysis treated extracts. However,
there was good agreement between both strains that manganese had a
stimulatory effect on end joining, which we confirmed in follow up
titrations. Similarly, we investigated the biochemical origins of the
ex vivo DNA assembly by titrating putative enzymes.
In E. coli, DSB repair, dominated by homologous recombination, relies
on the RecBCD complex to expose ssDNA ends and load RecA, forming the
nucleofilament that subsequently directs a homology search and strand
invasion of dsDNA64 – but this is different phenomena than directly
joining two ends of DNA together directly. Previously, it was shown
that recA− strains of E. coli join linear dsDNA with homologous
overhangs in lysate more efficiently than their RecA-expressing
counterparts13. However, we observed an interesting dichotomy
surrounding RecA. During our titrations using the linear assay, RecA
showed consistent enhanced assembly properties, but when applied to
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circular assemblies and transformations it showed a consistently
negative effect. It could be that RecA plays a role preserving the
ends of the linear DNA products, while the nucleases in recA- lysates
are free to degrade the product (and substrate) DNAs63. Either way, as
recBCD− strains have also been reported to direct accurate DNA end
joining, ex vivo assembly reactions may involve mechanisms independent
of homologous recombination machinery, perhaps by an alternative endjoining pathway29,87. We suspect that both ex vivo and in vivo DNA
assembly is likely facilitated by multiple competing DNA repair
mechanisms, but largely by RecBCD.
Exonuclease activity is required for DNA end resection, but is a
balancing act. We saw with yeast very little exonuclease activity,
which preserves the regions of homology, but may not expose
complementary overhangs. Conversely, extreme exonuclease activities,
like that of Deinococcus, may be resecting bi-directionally, deleting
the necessary homologous regions. Again, knockouts of exonucleases
implicated in deletion of exposed overhangs may greatly improve the
efficiency of end joining88. In our own titration experiments we saw
this effect with the addition of dsDNA exonucleases (RecBCD and
ExoIII). Certain ssDNA exonucleases also showed detrimental effects on
assembly (DNA PolI and RecJ), but there was significant substrate DNA
remaining in the lanes supporting the hypothesis that they possess the
ability to recess homology arms. In the cell ssDNA activity is
actually beneficial as a sort of check-and-balance to ensure the cell
can abort non-productive recombination events88. Previous studies have
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shown ExoI and RecJ knockouts have elevated mutational rates due to
the loss of this abortive activity88. These hypotheses would be very
convincing if the complete opposite effect weren’t observed in the
exact same study. During the titration ExoI and – at its lowest levels
– ExoT showed the ability to greatly enhance assembly, almost 8-fold
in some circumstances. These both have opposite polarities to the
inhibitory RecJ ssDNA exonuclease so there is clearly a preference for
degrading the 3’ extensions, rather than the 5’ extensions. While we
lacked the full library of strains needed to draw exquisite
conclusions, the equivalency between nuc4-.λR and XJa highlights the
complexity and redundancy of exonuclease activity and DNA repair
pathways89.
The final task at hand was to complete our ex vivo-based cloning
pipeline. To do so we designed a new plasmid that incorporated
features designed by the community (UNSs, riboJ), de novo designed
parts (RBS, Codon-optimized gene) and the screenable BCP cassette from
our own works. Using ex vivo assembly we recombined the plasmid
backbone together with two larger synthetic fragments in a very
effective manner. Based on 24 tested clones, all 24 contained the
correct size inserts. Out of 3 sent for subsequent sequencing only one
had no errors in the Pfu gene. This represents a clear win for ex vivo
DNA assembly as a very practical cloning tool. The Pfu polymerase was
at one time the highest-fidelity polymerase, though it has now been
replaced by more engineered, more expensive polymerases like Q5. The
assemblies showed a greatly elevated error rate based on an increased
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white:blue colony ratio, but this might be corrected simply by
removing the contaminating host DNA or performing PCR optimization
(e.g., annealing temperature, buffer composition, etc…).
With the successful transformation of assembly reactions derived from
both an optimized ex vivo DNA assembly and an ex vivo PCR, the project
has successfully completed it’s ultimate objective of establishing an
ex vivo cloning suite. Yet, given the outcomes of the experimentation
it is easy to instead focus on perceived shortcomings of the project.
There were many questions that remained unanswered, conflicting
results and components not carried to ‘full completion’ (i.e.,
generation of all nuclease-knockouts, optimization of ex vivo PCR).
Even more egregious for some is the lack of data backed by extensive
replicates. While understandable, this is simply a function of the
biological systems being studied, the objectives of the study and even
the ex vivo approach to the study.
Biological systems are inherently noisy and complex, meaning
establishing definitive causalities is a difficult task often not
accomplished in even the very deepest of investigations. Further, the
particular subcellular system being probed – DNA maintenance and
repair – is conserved amongst every living organism25. Such
conservation is indicative of the “do-or-die” nature of this pathway
and is reflected in the degree of redundancy and orchestration. By
using an approach like ex vivo that combines the throughput of an in
vitro system with endogenous complexity of an in vivo system,
investigations into these mechanisms can generate results that quickly
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deviate the project from the original objective into a very large
study all of it’s own.
Continued development of faster and cheaper DNA assembly and genetic
characterization methods, such as the ex vivo DNA cloning pipeline
described here, will further accessibility and success of DNA-based
studies and applications. As mentioned in detail, there were a number
of surprising findings throughout the study that could be pursued. The
first is the interesting case of ExoI. ExoI could be purchased and
titrated into lysates with many different host background genotypes to
investigate its contribution towards recombination/end joining.
Alternatively, modifications could be employed to try and modulate
native degradation. For example, using primers with non-standard
phosphodiester analogues – such as the phosphorothioate bond – could
be employed to halt degradation. This could be very helpful in the
linear assembly when the product is formed and subsequently degraded
from exposed termini before visualization. Building off the success of
the Pfu functionalized lysate, a multienzymatic functionalized lysate
featuring a ligase, polymerase and exonuclease could be constructed as
an ex vivo mimic of the tripartite Gibson assembly. Moreover,
functionalized lysates hold the potential to address some problems
unsuitable to living cultures. Biocontainment has become a major point
of contention for the employ of genetically modified organisms,
particularly in an environmental context90,91. By substituting a
functionalized lysate, the same systems can be applied as
bioremediation treatment without the risk of spreading throughout the
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environment, and without the tremendous costs associated with bulk
enzyme purification. While ex vivo engineering and ex vivo molecular
biology may not be the “silver bullet” to solve every societal
problem, there are many academic and industrial opportunities
addressable by ex vivo and synthetic biology.
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Chapter 7. Materials and Methods
7.1. Reagents, DNA and Enzymes
All chemical reagents were purchased from Sigma-Alrich. Divalent
metals used in titration experiments were all complexed with chloride
(i.e., MgCl2, MnCl2, CaCl2, ZnCl2) and formulated as 1 Molar Stock
solutions. All enzymes used in the titration experiment were purchased
from NEB, along with the Q5 polymerase used for PCR. All DNA synthesis
of primers and synthetic fragments was performed by IDT. The plasmids
used for 2-way and 3-way assembly experiments were obtained from the
Registry of Standard Biological Parts. Sequences for all DNA used are
provided in (DNA Sequences).

7.2. Generation of DNA Fragments for ex vivo DNA
Assembly
The templates, primers and products used for the assembly assays are
summarized in Appendix C.
7.2.1. PCR with Q5 DNA Polymerase
The DNA fragments used to demonstrate ex vivo DNA assembly were
generated using standard PCR of parts of the following plasmids from
the BioBricks registry: pSB1C3-J04450, pSB1C3-K592009, and pSB1K3J04450. Primers used in this study (Table C.1) were generated using
the j5 automated DNA assembly software92-94. Amplicons were generated by
100 µL PCR reactions with Q5 polymerase (NEB) under standard reaction
89

conditions. These reactions were cycled at 98°C for 30 s; 98°C for 10
s, 50°C for 15 s, 72°C for 25 s (repeated for 25 cycles); 72°C for
2:00. Resultant PCRs were subsequently purified using agarose gel
electrophoresis and extraction (Section 7.5).
7.2.2. ex vivo PCR with Pfu DNA polymerase
Pfu PCRs were formulated as follows (final concentration): 200 µM each
dNTP, 1X Q5 reaction buffer (2 mM MgCl2), 500 µM each primer and ~2 ng
template DNA per 50 µL reaction. These reactions were cycled
differently for small fragments (<1 kb) and large fragments (>1 kb).
For smaller pieces (i.e., BCP and Promoters): 95°C for 90 s; 95°C for
30 s, 55°C for 30 s, 73°C for 90 s (repeated for 28 cycles); 74°C for
3:00. For larger fragments (i.e., backbones, background controls):
95°C for 90 s; 95°C for 45 s, 55°C for 30 s, 73°C for 4 min (repeated
for 30 cycles); 74°C for 6:00. Resultant PCRs were subsequently
analyzed or purified purified using agarose gel (See, 7.5).

7.3. Preparation of Lysates
7.3.1. Initial Study
Cellular lysates were prepared from the following strains: E. coli
NEB10β (NEBTM #C3019), S. cerevisiae BY4741 and D. radiodurans R1
(ATCC® 13939). E. coli was grown in Terrific Broth with glycerol
(Sigma®) at 37°C with shaking at 250 rpm. D. radiodurans was grown in
123 TGY medium (5% Tryptone, 5% Yeast extract, 1% Glucose, 1%
Potassium monophosphate) at 30°C and S. cerevisiae was grown with YPD
media (SigmaTM) at 30°C, both shaking at 250 rpm. The preparation of
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the bacterial (E. coli and D. radiodurans) and the S. cerevisiae
lysates varied slightly: bacterial cultures were pelleted once
OD600nm= 6.00-6.50, while the yeast cultures were pelleted once
OD600nm= 4.00-4.50. Volumes of 4–6 mL of culture were centrifuged at
13,200 rpm at 4°C for 2 min, washed with 1 mL of Milli-Q H2O,
centrifuged again and the wet pellet massed. 2X CelLytic B Lysis
Reagent (SigmaTM) was added to the bacterial cell pellets at 3 µL/mg of
cells. 1X CelLytic Y Lysis Reagent (SigmaTM) was added to the yeast
pellets in the same ratio. After the addition of the lysis reagents,
the cells were incubated at 37°C for 10 min shaking at 300 rpm. The
lysed cells were centrifuged at 13,200 rpm for 15 min and a 20 µL
sample of the supernatant (lysate) was mixed with 20 µL of 100%
glycerol to yield 40 µL aliquots. All lysate aliquots were stored at
−20°C.
7.3.2. Optimized Methods
Cultures of E. coli were grown under similar conditions to those
reported in 7.3.1, with the exception that the cultures were
inoculated from starter cultures. For cultures using the autolysis
cassette, the media was supplemented with 3 mM L-arabinose and 10 mM
magnesium chloride from a 500X stock. Cultures were grown into
saturation (OD600nm= 2.0-4.0 after about 18 hours growth) and then
pelleted at 4200RPM at 4°C for 20 minutes. From this point on cells
were kept on ice. Media was aspirated, making sure to remove as much
as possible using a pipette tip and the pellets were massed (~75
milligrams per 5 mL) in pre-massed tubes. We found that tubes can vary
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significantly and accuracy is best when each tube is massed initially.
Cells were washed once with ice-cold 10% glycerol solution in order to
prevent premature lysis in a hypotonic solution by the autolysis
strains. For detergent lysis, cell pellets are resuspended in 1.5
volumes of CelLytic B 2X per milligram of pellet and incubated at 30°C
with shaking for 15 minutes. The resulting lysate is then diluted with
an additional 3.5 volumes of Lysis buffer (50 mM Tris-HCl, pH8; 0.2 mM
EDTA; 2 mM DTT; 200 mM NaCl; 0.2% Triton X-100; 0.1 mM PMSF).
Autolysis pellets are resuspended in 5 volumes of Lysis buffer and
frozen at -80°C or in liquid nitrogen. Thawing the tube in a room
temperature water bath lyses the autolysis strain. All lysates are
then spun at the highest speed (20,000xg) for 20 minutes at 4°C. The
resulting supernatant are very carefully aspirated into an equal
volume of glycerol, mixed thoroughly (with pipette or vortex) and
stored at -20°C.
7.3.3. ex vivo PCR Lysate
From an overnight culture, a SOB media (it is critical to use a medium
without glucose) culture is inoculated (at a 10-2 dilution) and
cultured at 37°C rotating at 250 RPM for about 2 hours. At this point
the L-Rhamnose inducer is added to 0.2% (from a filter sterilized 20%
solution). After another 3-24 hours the culture can be harvested at
8000xg and washed with 10% glycerol. The culture is lysed in 1.5
volumes of CelLytic B 2X and diluted to 5 volumes using lysis buffer
(see above). The entire lysate is then incubated at 75°C for 30
minutes, centrifuged at the highest speed (16,000xg) for 20 minutes at
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4°C and the supernatant aspirated into an equal volume of glycerol,
mixed thoroughly and stored at -20°C.

7.4. DNA Assembly Reactions
7.4.1. Initial Study
Buffers for assembly reactions were prepared from 100× stock
solutions. Stock solutions were as follows: 100 mM NADβ, 100 mM ATP,
100 mM DTT, 1 M MgCl232. Tris-HCl was added to the buffer to 500 mM
from a 1 M stock solution. A typical assembly reaction would include 6
µL of cellular lysate, 2 µL of 10× buffer, 2 µL of nuclease-free water
and 10 µL of a DNA master mix. DNA master mixes contained all
fragments needed for assembly and were formulated with 20 ng/µL of the
backbone and 6:1 molar ratio of insert fragments to the backbone.
7.4.2. Optimized and Supplemented Conditions
Buffers were also formulated from 100X stocks with the expection of
the divalent cation titrations. For these experiments a “base” buffer
with all components except for magnesium and water was formulated and
then aliquoted, then these aliquots were fully constituted with the
various cations and water to a 10X concentration. A typical assembly
optimized assembly was formulated as follows: 1 µL of 10X Buffer, 5 µL
of a 2X DNA Mastermix, 1 µL of 10X Lysate (at ~200 µg/mL) and 3 µL of
nuclease-free water. The DNA master mixes were formulated with 5 ng/µL
of the backbone fragment (BCP band for 2-way linear) and molar ratios
of 1.2:1 and 2:1.2:1 for 2-way (BCP:BB) and 3-way (Promoter:BCP:BB),
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respectively. These reactions were transferred immediately to the
thermocycler and incubated at 37°C for 2 hours. Upon completion
reactions were either used immediately for transformations or gel
electrophoresis, or frozen at -20°C until used.

7.5. Agarose Gel Analyses and Extraction
7.5.1. Initial Study
Gel analysis was performed using 1.0–1.2% agarose-TAE gels containing
GelRed (BiotiumTM) as the staining agent. All analytical gels were run
at 100 V for 30–50 min and visualized with a Molecular Imager® Gel
Doc™ XR+ Imaging System with Image Lab™ v4.0 software (Bio-Rad).
To purify PCR reactions, samples were run on 1.0% agarose-TAE gels
stained with GelGreen (BiotiumTM). The gels were run at 100 V for 30
min and subsequently visualized under blue light excitation. The gels
showed no side product formation and bands were excised and isolated
using ZymoCleanTM Gel DNA Recovery Kit (Zymo ResearchTM).
7.5.2. Optimized Analytical Gels
In the optimized format, analytical gels for 2-way linear reactions
were formulated at 1.8% agarose in TAE buffer. 3.5 µL of GelRed
(BiotiumTM; 50,000X in Water) was added to the molten gel and once
poured the gels were allowed to solidify for at least one hour. To
each 10 µL assembly reaction, 3 µL of 5X Loading Dye was added and 5
µL loaded. For Ladders (NEB 100-bp, 1kb or 2-log Quick-load) 3.8 µL
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were added to each lane. The gel was run at 180V for 1 minute, the run
at 90V for 35 minutes.
7.5.3. Gel Analysis
To analyze the gel they were visualized with a Molecular Imager® Gel
Doc™ XR+ Imaging System (Bio-Rad). Using Image Lab™ v4.0 software
(Bio-Rad) the lanes and bands were identified. The lane profile was
used to manually adjust bands with exceptional tailing or false peaks.
Using the Relative Quantity analysis tool, the BCP band of the
negative control is selected as the internal reference. Band
information was exported into a Comma Separated Values file for
subsequent analysis. Pictures of all gels not included in the main
text are provided in (Appendix B Gel Pictures).

7.6. Transformations and Preparation of Competent Cells
7.6.1. Initial Study
Transformations were performed using chemically competent E. coli
NEB10β (NEB) according to manufacturer’s recommendations. Briefly, 2
µL of reaction mixture (from ex vivo assemblies) or diluted DNA master
mix (for in vivo assembly) were added to each transformation, these
were incubated for 30 min on ice, heat shocked at 42°C, recovered in
950 µL SOC at 37°C for 60 min and 50 µL of culture was spread onto
agar plates containing the appropriate antibiotic.
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7.6.2. Optimized Competence and Transformation
To prepare chemicompetent E. coli for chemical transformation the
“Ultracompetent” method of Inoue, et al was followed closely95. As
there is not a refrigerated incubator available in our lab to culture
at 18°C the cultures were incubated at room temperature (~21°C).
To perform transformations, we incubated 48 µL of cells with 2 µL of
DNA sample on ice for 30 minutes. The cells were heat-shocked in a
42°C water bath for 45 seconds and immediately transferred and swirled
in an ice-water bath for 90 seconds. 950 µL of room temperature SOC
was added to the tube and it was moved to the 37°C incubator with
shaking at 250 RPM for 1 hour. Transformants were serially-diluted
into sterile PBS and 100 µL plated onto LB with the appropriate
antibiotic.
To prepare electrocompetent cells, we followed the protocol
“Transformation of E. coli by Electroporation” in the Molecular
Cloning Manual 4th ed. Electroporation reactions were carried out in a
Bio-Rad Micropulser using the same volumes as used for chemical
transformation above.
CFU per femtomole values were calculated by taking the raw counts of
countable plates (30-300), multiplying by the dilution factor and
dividing by the number of femtomoles of DNA transformed. Given the
backbone of ex vivo assemblies as the limiting substrate at 5 ng/µL, 2
µL equates to approximately 6.6 femtomoles of 2-way and 7.3 femtomoles
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of 3-way. 2 µL of a 50 pg/µL solution of pUC19 equates to 0.06
femtomoles.

7.7. Lambda RED Recombineering
Genomic manipulations of the nuc4- strains were performed using the
protocols laid out by Wang, et al77. Summarizing, a single cycle of
recombineering consisted of growing a culture of nuc4- in a 3 mL
culture of LB + Ampicillin until OD600 = ~0.4, inducing lambda
expression at 42°C for 15 minutes, washing 1 mL of the culture twice
with ultrapure water, concentrating at ~50 µL and transforming 2 µL of
a 10 µM solution of MAGE oligo(s)/ λR cassette. In order to modify
nuc4-, an already existing chloramphenicol cassette in the host genome
was deactivated using the cat_fwd_stop oligo (see Appendix C) and the
chloramphenicol mutant (nuc4-.Cm-) was isolated by replica plating.
The λR autolysis cassette (including chloramphenicol resistance) was
amplified out of XJa, gel extracted and transformed into nuc4-.Cm-.
Unfortunately, there was so much homology between the chloramphenicol
cassette in the λR autolysis cassette and the deactivated
chloramphenicol loci that many, many false-positive chloramphenicol
transformants were obtained (as confirmed by allele-specific PCR;
Table C.3). Instead to identify the correct integrants, a screen
approach utilizing Phenol Red Agar + 2% Arabinose was employed to
identify colonies unable to utilize arabinose. A positive clone was
isolated and the integration of the lysogen gene was confirmed by
allele-specific genotyping and a lytic phenotype. Sequences of all
oligos used for recombineering are provided in (Table C.3).
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Appendix A. Tables

Table A.1 Summary of Assemblies
2- way Circular (2WC)

Part

Template

Forward Primer

Reverse Primer

Length

BCP

pSB1C3-K592009

exda1

exda2

698

Backbone

pSB1K3-J04450

exda3

exda4

2446

2-way Linear (2WL)

Part

Template

Forward Primer

Reverse Primer

Length

Promoter

pSB1C3-J00450

exda22

exda23

381

BCP

pSB1C3-K592009

exda12

exda13

697

3-way Circular (3WC)

Part

Template

Forward Primer

Reverse Primer

Length

Backbone

pSB1K3-J04450

exda3

exda19

2214

Promoter

pSB1C3-J00450

exda20

exda21

387

BCP

pSB1C3-K592009

exda12

exda2

696

Description of the DNA fragments used in each assembly assay. DNA sequences for
primers, template plasmids and products of assemblies can be found in Appendix C.

1

Table A.2 Strain Genotypes
Strain

Parent

Synonymous

Growth

Strain

Strain

(Celsius;

Genotype

Resistance)

Δ(ara-leu) 7697 araD139

fhuA ΔlacX74

galK16 galE15 e14-

NEB10β

K-12

DH10Beta

37; Str

ϕ80dlacZΔM15
nupG

recA1 relA1 endA1

rpsL (StrR) rph spoT1 Δ(mrrhsdRMS-mcrBC)

F`[traD36 proA+B+ laclq ∆(lacZ)M15]
∆(lac-proAB) glnV44 (supE44) e14XJa

K-12

JM109

37; Cm

(McrA-) thi gyrA96 (NalR) endA1
hsdR17(rK- mK+) relA1 recA1 araB::λR,
cat (CmR)

F- λ- ilvG- rfb-50 rph-1 ΔmutS::cat
Δ(ybhB-bioAB)::[lcI857 N(cronuc4-

EcNR2

32; Amp Cm
ea59)::tetR-bla] xonA- recJ- xseAexoX-

F- λ- ilvG- rfb-50 rph-1 ΔmutS::catΔ(ybhB-bioAB)::[lcI857 N(cronuc4-.Cm-

nuc4-

32; Amp
ea59)::tetR-bla] xonA- recJ- xseAexoX-

F- λ- ilvG- rfb-50 rph-1 ΔmutS::catnuc4nuc4-.λR

Δ(ybhB-bioAB)::[lcI857 N(cro32; Amp Cm

.Cm-

ea59)::tetR-bla] xonA- recJ- xseAexoX- araB::λR, cat (CmR)

Genotypes of Strains used in the current study are presented above. Growth indicates
temperatures used to culture strain and resistances available to strain. Relevant
genotypes are indicated in bold and described below in Table A.3

2

Table A.3 Description of Relevant Genotypes
Genotype
recA1
endA1
rpsL
ΔmutS::cat
ΔmutS::cat-

Phenotypic Description
Disables homologous recombination pathways for reduced occurrence
of unwanted recombination in cloned DNA; cells UV sensitive
For cleaner preparations of DNA and better results in downstream
applications due to the elimination of non-specific digestion by
Endonuclease I
Mutation in ribosomal protein S12 conveying streptomycin
resistance
Deletion of mutS used for mismatch repair for better Lambda Red
recombination; Conveys Chloramphenicol Resistance
Inactivation of Chloramphenicol cassette by insertion of stop
codon
Lambda RED operon of alpha, beta and gamma proteins induced by
heat-shock; Cells must be cultured at lower temperatures; Conveys
Ampicillin resistance

lcI857
N(croea59)::tetRbla
araB::λR,
Insertion of Lambda phage endolysin inducible by arabinose;
cat (CmR)
Disrupts arabinose metabolism; Conveys Chloramphenicol resistance
xonA- recJInactivation of exonucleases (ExoI, RecJ, ExoVII, ExoX) by
xseA- exoXpremature stop codon insertion
Descriptions of relevant genotypes found in Table A.2

3

Table A.4 Unit Definitions of Enzymes used in Titrations
Supplied
Enzyme

Concentration

Temperature

Time

Buffer

30 min

NEB 4

[Substrate]

[Product]

Linear dsDNA (no

10 nmol (acid-soluble

concentration)

nucleotides)

170 ng/µL (ssDNA)

10 nmol

(Celsius)
(U/µL)

RecBCD

10

37

ExoI

20

37

30 min

1X ExoI

ExoIII

100

37

30 min

NEB 1

.15 mM (sonicated

1 nmol

dsDNA)

ExoT

RecJf

DNA

5

30

10

25

37

37

30 min

30 min

30 min

NEB 2

1X Eco

Eco
16

.1 nmol (TCA soluble

(polythymidine)

nucleotides)

30 ng/µL (sonicated

.05 nmol (TCA soluble

ssDNA)

nucleotides)

70 ng/µL SalmonSperm

10nmol (dNTPs -> acid

DNA; 33 µM dNTPs

insoluble material)

NEB 2

PolI

10

1 nmol
NEB 4

30 min

0.12 µM DNA termini

Ligase

Ligase

.06 µM ligated ends
(300 ng/µL)

Buffer

Unit definitions of enzymes supplied by NEB and used in titration experiments. For
exonucleases, exonuclease activity is measured as formation of acid-soluble
nucleotides. For DNA PolI polymerization activity is defined by formation of acid
insoluble material from dNTPs. E. coli Ligase activity is measured by the formation of
ligated ends from digested material. All reported unit definitions are for a 50 µL
reaction volume.

4

Appendix B. Gel Pictures
Below are the original agarose gel pictures used in the analysis of ex
vivo assembly. The higher molecular weight band (BCP band) in the
control lane (“C”) was used as the relative reference for band
intensities.
B.1.1 Time Course of Deinococcus, Saccharomyces, and E. coli lysates

Figure B.1 Dra, Sce and Eco Time Course

5

B.1.2 Lysate Preparation (Growth Phase, Media and Glycerol)

Figure B.2 Lysate Preparation (Gel 1)

6

Figure B.3 Lysate Preparation (Gel 2)

7

B.1.3 Concentration of Lysates

Figure B.4 Lysate Dilutions (60 minutes)

Figure B.5 Lysate Dilutions (120 minutes)

8

B.1.4 Buffer Optimization

Figure B.6 Buffer Optimization (NEB10β)

9

Figure B.7 Buffer Optimization (XJa Autolysis)

10

B.1.5 Buffer Titration

Figure B.8 Buffer Titration (NEB10β #1)

11

Figure B.9 Buffer Titration (NEB10β #2)

12

Figure B.10 Buffer Titration (XJa)

13

B.1.6 Manganese Titration

Figure B.11 Manganese Titration (NEB10β)

14

B.1.7 Enzymatic Titrations

Figure B.12 RecBCD, PolI, RecA, Eco Ligase Titration

15

Figure B.13 ssDNA Exonucleases Titration

16

B.1.8 RecA Titration

Figure B.14 RecA Titration (XJa Autolysis)

17

Appendix C. DNA Sequences
C.1 Primer Sequences
Table C.1 ex vivo Assembly Assay Primers
Primer
Sequence

Length

exda1

AGAGAAAGAGGAGAAAATGAGTGTGATCGCTAAACAAATGACCTACAAGG

50

exda2

ATTTGATGCCTGGTTATTAGGCGACCACAGGTTTGCGTGC

40

exda3

GGTCGCCTAATAACCAGGCATCAAATAAAACGAAAGGCT

39

exda4

GCGATCACACTCATTTTCTCCTCTTTCTCTAGTATGTGTGA

41

exda12

AGGAGAAATACTAGATGAGTGTGATCGCTAAACAAATGACCTACAAGG

48

exda13

GCCTGGCTCTAGTATTATTAGGCGACCACAGGTTTGCGTGC

41

exda14

GGTCGCCTAATAATACTAGAGCCAGGCATCAAATAAAACG

40

exda19

TGGTTTCTTAGAAGCTGATCCTTCAACTCAGCA

33

exda20

TGAGTTGAAGGATCAGCTTCTAAGAAACCATTATTATCATGACATTAACC

50

exda21

AGCGATCACACTCATCTAGTATTTCTCCTCTTTCTCTAGTATGTG

45

exda22

TGAAGGATCAGCTTCTAAGAAACCATTATTATCATGACATTAACC

45

exda23

GCGATCACACTCATCTAGTATTTCTCCTCTTTCTCTAGTATGTG

44

18

Table C.2 pUN and UNS Primers
Primer

Sequence

Length

UNS1F

CATTACTCGCATCCATTCTCAG

22

UNS1R

GAGACGAGACGAGACAGC

18

UNS2F

GCTGGGAGTTCGTAGACG

18

UNS2R

GCTTGGATTCTGCGTTTGT

19

UNS3F

GCACTGAAGGTCCTCAATC

19

UNS3R

CGACCTTGATGTTTCCAGTG

20

UNS4F

CTGACCTCCTGCCAGC

16

UNS4R

GACTTTGCGTGTTGTCTTACT

21

UNS5F

GAGCCAACTCCCTTTACAAC

20

UNS5R

CTCTAACGGACTTGAGTGAGG

21

UNS6F

CTCGTTCGCTGCCACC

16

UNS6R

GTATGTGACCGTAGAGTATTCTTAG

25

UNS7F

CAAGACGCTGGCTCTGA

17

UNS7R

CGAGTAGTTCAGTAGCGGA

19

UNS8F

CCTCGTCTCAACCAAAGC

18

UNS8R

CCAGGTGGTTGATGGGT

17

19

UNS9F

GTTCCTTATCATCTGGCGAATC

22

UNS9R

CAGTGCTCTTGTGGGTC

17

UNSXF

CCAGGATACATAGATTACCACAAC

24

UNSXR

GGTGGAAGGGCTCGG

15

pGERC-BB_F

TCGAGAAGGACACGGTTA

18

pGERC-BB_R

AAAGCCTTGTATGCTTCTTT

20

20

Table C.3 Oligos and Primers used for Strain Engineering
Product
Oligo Name
Sequence
Length

Purpose

G*C*A*T*CGTAAAGAACATTTTGA
GGCATTTCAGTCAGTTGCTCAATGA
cat_fwd_stop

Introduces Stop Codon
NA

ACCTATAACCAGACCGTTCAGCTGG

into cat gene of nuc4-

ATATTACGGCCTTTTTAAA
C*A*A*A*TTGTTTCTCAATCTGGC
CCAGTGCTGCCGCCAACGCTcaCTa
recA.KO

Introduces Stop Codon
NA

TTaGTTTTCGTCGATAGCCATTTTT

into recA gene

ACTCCTGTCATGCCGGGTA
T*C*G*T*TTTAACACGGAGTAAGT
GATGTACCGTTATTTGTCTATTGCT
endA.KO

Introduces Stop Codon
NA

GCtGaGTGGTACTGAGCGCAGCATT

into endA gene

TTCCGGCCCGGCGTTGGCC
Amplifies entire
arabinose loci
araB_lambdaR-f

CTTCGCCCGCAAAGCCGTAA

2066

including endolysin and
cat genes; Allelespecific PCR
Amplifies entire
arabinose loci

araB_lambdaR-r

ACAGGTCGCTGAAATGCGGC

2066
including endolysin and
cat genes

21

Targets LambdaR coding
asLambdaR-r

GGTCAGTTCGAGCATAAGGC

20

sequence; AlleleSpecific PCR
Allele-specifc PCR of

endA.KO.v2_wt-f

CGTTATTTGTCTATTGCTGCGG

191
endA
Allele-specifc PCR of

endA.KO*_mut-f

CCGTTATTTGTCTATTGCTGCTGA

191
endA
Allele-specifc PCR of

endA.KO*-r

GCACGATTGCAGATCAACAACG

191
endA
Allele-specific PCR of

recA.KO.v2_wt-f

TGCCGCCAACGCTTT

474
recA
Allele-specific PCR of

recA.KO.v2_mut-f

TGCCGCCAACGCTCA

474
recA
Allele-specific PCR of

recA.KO.v3-r

GGTTTGAACGCGGATTTGTCAG

474
recA

22

C.2 Plasmid Sequences
Below are Genbank formatted files of the various plasmids used
throughout the study, complete with annotations.
C.2.1 pSB1C3-J00450 (RFP expression)
LOCUS

pSB1C3-J00450

3139 bp ds-DNA

2015
DEFINITION

.

ACCESSION

pSB1C3-J00450

VERSION

pSB1C3-J00450

FEATURES
terminator

Location/Qualifiers
3099..3139
/label="B0012"

terminator

3011..3139
/label="BBa_B0015"

rep_origin

261..875
/label="pMB1 rep origin"

terminator

1042..1147
/label="T0 terminator"

RBS

2279..2290

23

circular

22-APR-

/label="B0034"
misc_feature

3106..3125
/label="B0012 Stem-loop"

misc_binding

2049..2070
/label="BioBrick prefix"

primer_bind

12..33
/label="SB-prep-3P-1 primer site"

primer_bind

2031..2054
/label="SB-prep_2Ea primer site"

CDS

1160..1829
/label="CmR"

CDS

2297..3002
/label="E1010"

misc_feature

3114..3117
/label="B0012 Loop"

misc_binding

1..21
/label="BioBrick suffix"

misc_feature

3022..3065

24

/label="B0010 Stem-loop"
terminator

3011..3090
/label="B0010"

primer_bind

156..176
/label="VR primer site"

primer_bind

1943..1962
/label="VF2 primer site"

promoter

2071..2270
/label="R0010"

terminator

22..93
/label="Eco His Term."

misc_feature

3042..3045
/label="B1010 Loop"

ORIGIN
1 tactagtagc ggccgctgca gtccggcaaa aaagggcaag gtgtcaccac cctgcccttt
61 ttctttaaaa ccgaaaagat tacttcgcgt tatgcaggct tcctcgctca ctgactcgct
121 gcgctcggtc gttcggctgc ggcgagcggt atcagctcac tcaaaggcgg taatacggtt
181 atccacagaa tcaggggata acgcaggaaa gaacatgtga gcaaaaggcc agcaaaaggc

25

241 caggaaccgt aaaaaggccg cgttgctggc gtttttccac aggctccgcc cccctgacga
301 gcatcacaaa aatcgacgct caagtcagag gtggcgaaac ccgacaggac tataaagata
361 ccaggcgttt ccccctggaa gctccctcgt gcgctctcct gttccgaccc tgccgcttac
421 cggatacctg tccgcctttc tcccttcggg aagcgtggcg ctttctcata gctcacgctg
481 taggtatctc agttcggtgt aggtcgttcg ctccaagctg ggctgtgtgc acgaaccccc
541 cgttcagccc gaccgctgcg ccttatccgg taactatcgt cttgagtcca acccggtaag
601 acacgactta tcgccactgg cagcagccac tggtaacagg attagcagag cgaggtatgt
661 aggcggtgct acagagttct tgaagtggtg gcctaactac ggctacacta gaagaacagt
721 atttggtatc tgcgctctgc tgaagccagt taccttcgga aaaagagttg gtagctcttg
781 atccggcaaa caaaccaccg ctggtagcgg tggttttttt gtttgcaagc agcagattac
841 gcgcagaaaa aaaggatctc aagaagatcc tttgatcttt tctacggggt ctgacgctca
901 gtggaacgaa aactcacgtt aagggatttt ggtcatgaga ttatcaaaaa ggatcttcac
961 ctagatcctt ttaaattaaa aatgaagttt taaatcaatc taaagtatat atgagtaaac
1021 ttggtctgac agctcgaggc ttggattctc accaataaaa aacgcccggc ggcaaccgag
1081 cgttctgaac aaatccagat ggagttctga ggtcattact ggatctatca acaggagtcc
1141 aagcgagctc gatatcaaat tacgccccgc cctgccactc atcgcagtac tgttgtaatt
1201 cattaagcat tctgccgaca tggaagccat cacaaacggc atgatgaacc tgaatcgcca
1261 gcggcatcag caccttgtcg ccttgcgtat aatatttgcc catggtgaaa acgggggcga

26

1321 agaagttgtc catattggcc acgtttaaat caaaactggt gaaactcacc cagggattgg
1381 ctgagacgaa aaacatattc tcaataaacc ctttagggaa ataggccagg ttttcaccgt
1441 aacacgccac atcttgcgaa tatatgtgta gaaactgccg gaaatcgtcg tggtattcac
1501 tccagagcga tgaaaacgtt tcagtttgct catggaaaac ggtgtaacaa gggtgaacac
1561 tatcccatat caccagctca ccgtctttca ttgccatacg aaattccgga tgagcattca
1621 tcaggcgggc aagaatgtga ataaaggccg gataaaactt gtgcttattt ttctttacgg
1681 tctttaaaaa ggccgtaata tccagctgaa cggtctggtt ataggtacat tgagcaactg
1741 actgaaatgc ctcaaaatgt tctttacgat gccattggga tatatcaacg gtggtatatc
1801 cagtgatttt tttctccatt ttagcttcct tagctcctga aaatctcgat aactcaaaaa
1861 atacgcccgg tagtgatctt atttcattat ggtgaaagtt ggaacctctt acgtgcccga
1921 tcaactcgag tgccacctga cgtctaagaa accattatta tcatgacatt aacctataaa
1981 aataggcgta tcacgaggca gaatttcaga taaaaaaaat ccttagcttt cgctaaggat
2041 gatttctgga attcgcggcc gcttctagag caatacgcaa accgcctctc cccgcgcgtt
2101 ggccgattca ttaatgcagc tggcacgaca ggtttcccga ctggaaagcg ggcagtgagc
2161 gcaacgcaat taatgtgagt tagctcactc attaggcacc ccaggcttta cactttatgc
2221 ttccggctcg tatgttgtgt ggaattgtga gcggataaca atttcacaca tactagagaa
2281 agaggagaaa tactagatgg cttcctccga agacgttatc aaagagttca tgcgtttcaa
2341 agttcgtatg gaaggttccg ttaacggtca cgagttcgaa atcgaaggtg aaggtgaagg

27

2401 tcgtccgtac gaaggtaccc agaccgctaa actgaaagtt accaaaggtg gtccgctgcc
2461 gttcgcttgg gacatcctgt ccccgcagtt ccagtacggt tccaaagctt acgttaaaca
2521 cccggctgac atcccggact acctgaaact gtccttcccg gaaggtttca aatgggaacg
2581 tgttatgaac ttcgaagacg gtggtgttgt taccgttacc caggactcct ccctgcaaga
2641 cggtgagttc atctacaaag ttaaactgcg tggtaccaac ttcccgtccg acggtccggt
2701 tatgcagaaa aaaaccatgg gttgggaagc ttccaccgaa cgtatgtacc cggaagacgg
2761 tgctctgaaa ggtgaaatca aaatgcgtct gaaactgaaa gacggtggtc actacgacgc
2821 tgaagttaaa accacctaca tggctaaaaa accggttcag ctgccgggtg cttacaaaac
2881 cgacatcaaa ctggacatca cctcccacaa cgaagactac accatcgttg aacagtacga
2941 acgtgctgaa ggtcgtcact ccaccggtgc ttaataacgc tgatagtgct agtgtagatc
3001 gctactagag ccaggcatca aataaaacga aaggctcagt cgaaagactg ggcctttcgt
3061 tttatctgtt gtttgtcggt gaacgctctc tactagagtc acactggctc accttcgggt
3121 gggcctttct gcgtttata
//

28

C.2.2 pSB1C3-K592009 (Contains BCP Coding Sequence)
LOCUS

pSB1C3-K592009

2739 bp ds-DNA

2015
DEFINITION

.

COMMENT

ApEinfo:methylated:1

FEATURES
misc_binding

Location/Qualifiers
670..690
/label="BioBrick suffix"

primer_bind

825..845
/label="VR primer site"

CDS

1..669
/label="amilCP"

terminator

691..762
/label="Eco His Term."

primer_bind

2700..2723
/label="SB-prep_2Ea primer site"

rep_origin

930..1544
/label="pMB1 rep origin"

primer_bind

2612..2631

29

circular

27-JUN-

/label="VF2 primer site"
primer_bind

2640..2666
/label="pSBamil_rev"

CDS

1829..2498
/label="CmR"

terminator

1711..1816
/label="T0 terminator"

misc_binding

2718..2739
/label="BioBrick prefix"

primer_bind

81..102
/label="pSBamil_for"

primer_bind

681..702
/label="SB-prep-3P-1 primer site"

ORIGIN
1 atgagtgtga tcgctaaaca aatgacctac aaggtttata tgtcaggcac ggtcaatgga
61 cactactttg aggtcgaagg cgatggaaaa ggtaagccct acgaggggga gcagacggta
121 aagctcactg tcaccaaggg cggacctctg ccatttgctt gggatatttt atcaccacag
181 tgtcagtacg gaagcatacc attcaccaag taccctgaag acatccctga ctatgtaaag

30

241 cagtcattcc cggagggcta tacatgggag aggatcatga actttgaaga tggtgcagtg
301 tgtactgtca gcaatgattc cagcatccaa ggcaactgtt tcatctacca tgtcaagttc
361 tctggtttga actttcctcc caatggacct gtcatgcaga agaagacaca gggctgggaa
421 cccaacactg agcgtctctt tgcacgagat ggaatgctgc taggaaacaa ctttatggct
481 ctgaagttag aaggaggcgg tcactatttg tgtgaattta aaactactta caaggcaaag
541 aagcctgtga agatgccagg gtatcactat gttgaccgca aactggatgt aaccaatcac
601 aacaaggatt acacttcggt tgagcagtgt gaaatttcca ttgcacgcaa acctgtggtc
661 gcctaataat actagtagcg gccgctgcag tccggcaaaa aagggcaagg tgtcaccacc
721 ctgccctttt tctttaaaac cgaaaagatt acttcgcgtt atgcaggctt cctcgctcac
781 tgactcgctg cgctcggtcg ttcggctgcg gcgagcggta tcagctcact caaaggcggt
841 aatacggtta tccacagaat caggggataa cgcaggaaag aacatgtgag caaaaggcca
901 gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg tttttccaca ggctccgccc
961 ccctgacgag catcacaaaa atcgacgctc aagtcagagg tggcgaaacc cgacaggact
1021 ataaagatac caggcgtttc cccctggaag ctccctcgtg cgctctcctg ttccgaccct
1081 gccgcttacc ggatacctgt ccgcctttct cccttcggga agcgtggcgc tttctcatag
1141 ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca
1201 cgaacccccc gttcagcccg accgctgcgc cttatccggt aactatcgtc ttgagtccaa
1261 cccggtaaga cacgacttat cgccactggc agcagccact ggtaacagga ttagcagagc

31

1321 gaggtatgta ggcggtgcta cagagttctt gaagtggtgg cctaactacg gctacactag
1381 aagaacagta tttggtatct gcgctctgct gaagccagtt accttcggaa aaagagttgg
1441 tagctcttga tccggcaaac aaaccaccgc tggtagcggt ggtttttttg tttgcaagca
1501 gcagattacg cgcagaaaaa aaggatctca agaagatcct ttgatctttt ctacggggtc
1561 tgacgctcag tggaacgaaa actcacgtta agggattttg gtcatgagat tatcaaaaag
1621 gatcttcacc tagatccttt taaattaaaa atgaagtttt aaatcaatct aaagtatata
1681 tgagtaaact tggtctgaca gctcgaggct tggattctca ccaataaaaa acgcccggcg
1741 gcaaccgagc gttctgaaca aatccagatg gagttctgag gtcattactg gatctatcaa
1801 caggagtcca agcgagctcg atatcaaatt acgccccgcc ctgccactca tcgcagtact
1861 gttgtaattc attaagcatt ctgccgacat ggaagccatc acaaacggca tgatgaacct
1921 gaatcgccag cggcatcagc accttgtcgc cttgcgtata atatttgccc atggtgaaaa
1981 cgggggcgaa gaagttgtcc atattggcca cgtttaaatc aaaactggtg aaactcaccc
2041 agggattggc tgagacgaaa aacatattct caataaaccc tttagggaaa taggccaggt
2101 tttcaccgta acacgccaca tcttgcgaat atatgtgtag aaactgccgg aaatcgtcgt
2161 ggtattcact ccagagcgat gaaaacgttt cagtttgctc atggaaaacg gtgtaacaag
2221 ggtgaacact atcccatatc accagctcac cgtctttcat tgccatacga aattccggat
2281 gagcattcat caggcgggca agaatgtgaa taaaggccgg ataaaacttg tgcttatttt
2341 tctttacggt ctttaaaaag gccgtaatat ccagctgaac ggtctggtta taggtacatt
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2401 gagcaactga ctgaaatgcc tcaaaatgtt ctttacgatg ccattgggat atatcaacgg
2461 tggtatatcc agtgattttt ttctccattt tagcttcctt agctcctgaa aatctcgata
2521 actcaaaaaa tacgcccggt agtgatctta tttcattatg gtgaaagttg gaacctctta
2581 cgtgcccgat caactcgagt gccacctgac gtctaagaaa ccattattat catgacatta
2641 acctataaaa ataggcgtat cacgaggcag aatttcagat aaaaaaaatc cttagctttc
2701 gctaaggatg atttctggaa ttcgcggccg cttctagag
//
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C.2.3 pSB1K3-J00450 (RFP expression with Kanamycin Resistance)
LOCUS

pSB1K3-J04450

3273 bp ds-DNA

circular

21-APR-

2015
DEFINITION

.

FEATURES
stem_loop

Location/Qualifiers
30..64
/label="Stem loop"

CDS

2431..3136
/label="E1010"

misc_feature

3240..3259
/label="B0012 Stem-loop"

primer_bind

complement(157..176)
/label="Verification reverse (VR) primer binding site"

gene

2205..3273
/label="BBa_J04450"

misc_feature

1..21
/label="DNA: BioBrick suffix"

misc_feature

2183..2204
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/label="Biobrick Prefix Standard (RFC10)"
terminator

3233..3273
/label="B0012"

misc_difference complement(1880..1880)
/label="Silent Mut: G->C mutation to remove XhoI site"
terminator

3145..3224
/label="B0010"

promoter

2205..2404
/label="R0010"

primer_bind

2067..2086
/label="Verification forward (VF2) primer binding site"

terminator

3145..3273
/label="BBa_B0015"

misc_feature

3248..3251
/label="B0012 Loop"

stem_loop

22..93
/label="E. coli his operon terminator"

misc_feature

complement(2017..2060)
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/label="repeat region misc"
misc_feature

3156..3199
/label="B0010 Stem-loop"

RBS

2413..2424
/label="B0034"

misc_feature

complement(261..875)
/label="rep (pMB1) misc"

misc_feature

3176..3179
/label="B1010 Loop"

misc_feature

276..276
/label="ORI misc"

stem_loop

complement(2143..2146)
/label="end of terminator"

stem_loop

complement(2156..2175)
/label="Stem loop"

misc_feature

1..21
/label="Biobrick Suffix (RFC10)"

CDS

complement(1097..1912)

36

/label="Kanamycin resistance marker CDS"
ORIGIN
1 tactagtagc ggccgctgca gtccggcaaa aaagggcaag gtgtcaccac cctgcccttt
61 ttctttaaaa ccgaaaagat tacttcgcgt tatgcaggct tcctcgctca ctgactcgct
121 gcgctcggtc gttcggctgc ggcgagcggt atcagctcac tcaaaggcgg taatacggtt
181 atccacagaa tcaggggata acgcaggaaa gaacatgtga gcaaaaggcc agcaaaaggc
241 caggaaccgt aaaaaggccg cgttgctggc gtttttccac aggctccgcc cccctgacga
301 gcatcacaaa aatcgacgct caagtcagag gtggcgaaac ccgacaggac tataaagata
361 ccaggcgttt ccccctggaa gctccctcgt gcgctctcct gttccgaccc tgccgcttac
421 cggatacctg tccgcctttc tcccttcggg aagcgtggcg ctttctcata gctcacgctg
481 taggtatctc agttcggtgt aggtcgttcg ctccaagctg ggctgtgtgc acgaaccccc
541 cgttcagccc gaccgctgcg ccttatccgg taactatcgt cttgagtcca acccggtaag
601 acacgactta tcgccactgg cagcagccac tggtaacagg attagcagag cgaggtatgt
661 aggcggtgct acagagttct tgaagtggtg gcctaactac ggctacacta gaagaacagt
721 atttggtatc tgcgctctgc tgaagccagt taccttcgga aaaagagttg gtagctcttg
781 atccggcaaa caaaccaccg ctggtagcgg tggttttttt gtttgcaagc agcagattac
841 gcgcagaaaa aaaggatctc aagaagatcc tttgatcttt tctacggggt ctgacgctca
901 gtggaacgaa aactcacgtt aagggatttt ggtcatgaga ttatcaaaaa ggatcttcac
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961 ctagatcctt ttaaattaaa aatgaagttt taaatcaatc taaagtatat atgagtaaac
1021 ttggtctgac agctcgagtc ccgtcaagtc agcgtaatgc tctgccagtg ttacaaccaa
1081 ttaaccaatt ctgattagaa aaactcatcg agcatcaaat gaaactgcaa tttattcata
1141 tcaggattat caataccata tttttgaaaa agccgtttct gtaatgaagg agaaaactca
1201 ccgaggcagt tccataggat ggcaagatcc tggtatcggt ctgcgattcc gactcgtcca
1261 acatcaatac aacctattaa tttcccctcg tcaaaaataa ggttatcaag tgagaaatca
1321 ccatgagtga cgactgaatc cggtgagaat ggcaaaagct tatgcatttc tttccagact
1381 tgttcaacag gccagccatt acgctcgtca tcaaaatcac tcgcatcaac caaaccgtta
1441 ttcattcgtg attgcgcctg agcgagacga aatacgcgat cgctgttaaa aggacaatta
1501 caaacaggaa tcgaatgcaa ccggcgcagg aacactgcca gcgcatcaac aatattttca
1561 cctgaatcag gatattcttc taatacctgg aatgctgttt tcccggggat cgcagtggtg
1621 agtaaccatg catcatcagg agtacggata aaatgcttga tggtcggaag aggcataaat
1681 tccgtcagcc agtttagtct gaccatctca tctgtaacat cattggcaac gctacctttg
1741 ccatgtttca gaaacaactc tggcgcatcg ggcttcccat acaatcgata gattgtcgca
1801 cctgattgcc cgacattatc gcgagcccat ttatacccat ataaatcagc atccatgttg
1861 gaatttaatc gcggcctgga gcaagacgtt tcccgttgaa tatggctcat aacacccctt
1921 gtattactgt ttatgtaagc agacagtttt attgttcatg atgatatatt tttatcttgt
1981 gcaatgtaac atcagagatt ttgagacaca acgtggcttt gttgaataaa tcgaactttt
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2041 gctgagttga aggatcagct cgagtgccac ctgacgtcta agaaaccatt attatcatga
2101 cattaaccta taaaaatagg cgtatcacga ggcagaattt cagataaaaa aaatccttag
2161 ctttcgctaa ggatgatttc tggaattcgc ggccgcttct agagcaatac gcaaaccgcc
2221 tctccccgcg cgttggccga ttcattaatg cagctggcac gacaggtttc ccgactggaa
2281 agcgggcagt gagcgcaacg caattaatgt gagttagctc actcattagg caccccaggc
2341 tttacacttt atgcttccgg ctcgtatgtt gtgtggaatt gtgagcggat aacaatttca
2401 cacatactag agaaagagga gaaatactag atggcttcct ccgaagacgt tatcaaagag
2461 ttcatgcgtt tcaaagttcg tatggaaggt tccgttaacg gtcacgagtt cgaaatcgaa
2521 ggtgaaggtg aaggtcgtcc gtacgaaggt acccagaccg ctaaactgaa agttaccaaa
2581 ggtggtccgc tgccgttcgc ttgggacatc ctgtccccgc agttccagta cggttccaaa
2641 gcttacgtta aacacccggc tgacatcccg gactacctga aactgtcctt cccggaaggt
2701 ttcaaatggg aacgtgttat gaacttcgaa gacggtggtg ttgttaccgt tacccaggac
2761 tcctccctgc aagacggtga gttcatctac aaagttaaac tgcgtggtac caacttcccg
2821 tccgacggtc cggttatgca gaaaaaaacc atgggttggg aagcttccac cgaacgtatg
2881 tacccggaag acggtgctct gaaaggtgaa atcaaaatgc gtctgaaact gaaagacggt
2941 ggtcactacg acgctgaagt taaaaccacc tacatggcta aaaaaccggt tcagctgccg
3001 ggtgcttaca aaaccgacat caaactggac atcacctccc acaacgaaga ctacaccatc
3061 gttgaacagt acgaacgtgc tgaaggtcgt cactccaccg gtgcttaata acgctgatag
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3121 tgctagtgta gatcgctact agagccaggc atcaaataaa acgaaaggct cagtcgaaag
3181 actgggcctt tcgttttatc tgttgtttgt cggtgaacgc tctctactag agtcacactg
3241 gctcaccttc gggtgggcct ttctgcgttt ata
//
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C.2.4 Circular Assembly Product (in Kanamycin Backbone)
LOCUS

pSB1K3-J04450

3273 bp ds-DNA

circular

21-APR-

2015
DEFINITION

.

FEATURES
stem_loop

Location/Qualifiers
30..64
/label="Stem loop"

CDS

2431..3136
/label="E1010"

misc_feature

3240..3259
/label="B0012 Stem-loop"

primer_bind

complement(157..176)
/label="Verification reverse (VR) primer binding site"

gene

2205..3273
/label="BBa_J04450"

misc_feature

1..21
/label="DNA: BioBrick suffix"

misc_feature

2183..2204
/label="Biobrick Prefix Standard (RFC10)"
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terminator

3233..3273
/label="B0012"

misc_difference complement(1880..1880)
/label="Silent Mut: G->C mutation to remove XhoI site"
terminator

3145..3224
/label="B0010"

promoter

2205..2404
/label="R0010"

primer_bind

2067..2086
/label="Verification forward (VF2) primer binding site"

terminator

3145..3273
/label="BBa_B0015"

misc_feature

3248..3251
/label="B0012 Loop"

stem_loop

22..93
/label="E. coli his operon terminator"

misc_feature

complement(2017..2060)
/label="repeat region misc"
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misc_feature

3156..3199
/label="B0010 Stem-loop"

RBS

2413..2424
/label="B0034"

misc_feature

complement(261..875)
/label="rep (pMB1) misc"

misc_feature

3176..3179
/label="B1010 Loop"

misc_feature

276..276
/label="ORI misc"

stem_loop

complement(2143..2146)
/label="end of terminator"

stem_loop

complement(2156..2175)
/label="Stem loop"

misc_feature

1..21
/label="Biobrick Suffix (RFC10)"

CDS

complement(1097..1912)
/label="Kanamycin resistance marker CDS"

43

ORIGIN
1 tactagtagc ggccgctgca gtccggcaaa aaagggcaag gtgtcaccac cctgcccttt
61 ttctttaaaa ccgaaaagat tacttcgcgt tatgcaggct tcctcgctca ctgactcgct
121 gcgctcggtc gttcggctgc ggcgagcggt atcagctcac tcaaaggcgg taatacggtt
181 atccacagaa tcaggggata acgcaggaaa gaacatgtga gcaaaaggcc agcaaaaggc
241 caggaaccgt aaaaaggccg cgttgctggc gtttttccac aggctccgcc cccctgacga
301 gcatcacaaa aatcgacgct caagtcagag gtggcgaaac ccgacaggac tataaagata
361 ccaggcgttt ccccctggaa gctccctcgt gcgctctcct gttccgaccc tgccgcttac
421 cggatacctg tccgcctttc tcccttcggg aagcgtggcg ctttctcata gctcacgctg
481 taggtatctc agttcggtgt aggtcgttcg ctccaagctg ggctgtgtgc acgaaccccc
541 cgttcagccc gaccgctgcg ccttatccgg taactatcgt cttgagtcca acccggtaag
601 acacgactta tcgccactgg cagcagccac tggtaacagg attagcagag cgaggtatgt
661 aggcggtgct acagagttct tgaagtggtg gcctaactac ggctacacta gaagaacagt
721 atttggtatc tgcgctctgc tgaagccagt taccttcgga aaaagagttg gtagctcttg
781 atccggcaaa caaaccaccg ctggtagcgg tggttttttt gtttgcaagc agcagattac
841 gcgcagaaaa aaaggatctc aagaagatcc tttgatcttt tctacggggt ctgacgctca
901 gtggaacgaa aactcacgtt aagggatttt ggtcatgaga ttatcaaaaa ggatcttcac
961 ctagatcctt ttaaattaaa aatgaagttt taaatcaatc taaagtatat atgagtaaac
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1021 ttggtctgac agctcgagtc ccgtcaagtc agcgtaatgc tctgccagtg ttacaaccaa
1081 ttaaccaatt ctgattagaa aaactcatcg agcatcaaat gaaactgcaa tttattcata
1141 tcaggattat caataccata tttttgaaaa agccgtttct gtaatgaagg agaaaactca
1201 ccgaggcagt tccataggat ggcaagatcc tggtatcggt ctgcgattcc gactcgtcca
1261 acatcaatac aacctattaa tttcccctcg tcaaaaataa ggttatcaag tgagaaatca
1321 ccatgagtga cgactgaatc cggtgagaat ggcaaaagct tatgcatttc tttccagact
1381 tgttcaacag gccagccatt acgctcgtca tcaaaatcac tcgcatcaac caaaccgtta
1441 ttcattcgtg attgcgcctg agcgagacga aatacgcgat cgctgttaaa aggacaatta
1501 caaacaggaa tcgaatgcaa ccggcgcagg aacactgcca gcgcatcaac aatattttca
1561 cctgaatcag gatattcttc taatacctgg aatgctgttt tcccggggat cgcagtggtg
1621 agtaaccatg catcatcagg agtacggata aaatgcttga tggtcggaag aggcataaat
1681 tccgtcagcc agtttagtct gaccatctca tctgtaacat cattggcaac gctacctttg
1741 ccatgtttca gaaacaactc tggcgcatcg ggcttcccat acaatcgata gattgtcgca
1801 cctgattgcc cgacattatc gcgagcccat ttatacccat ataaatcagc atccatgttg
1861 gaatttaatc gcggcctgga gcaagacgtt tcccgttgaa tatggctcat aacacccctt
1921 gtattactgt ttatgtaagc agacagtttt attgttcatg atgatatatt tttatcttgt
1981 gcaatgtaac atcagagatt ttgagacaca acgtggcttt gttgaataaa tcgaactttt
2041 gctgagttga aggatcagct cgagtgccac ctgacgtcta agaaaccatt attatcatga
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2101 cattaaccta taaaaatagg cgtatcacga ggcagaattt cagataaaaa aaatccttag
2161 ctttcgctaa ggatgatttc tggaattcgc ggccgcttct agagcaatac gcaaaccgcc
2221 tctccccgcg cgttggccga ttcattaatg cagctggcac gacaggtttc ccgactggaa
2281 agcgggcagt gagcgcaacg caattaatgt gagttagctc actcattagg caccccaggc
2341 tttacacttt atgcttccgg ctcgtatgtt gtgtggaatt gtgagcggat aacaatttca
2401 cacatactag agaaagagga gaaatactag atggcttcct ccgaagacgt tatcaaagag
2461 ttcatgcgtt tcaaagttcg tatggaaggt tccgttaacg gtcacgagtt cgaaatcgaa
2521 ggtgaaggtg aaggtcgtcc gtacgaaggt acccagaccg ctaaactgaa agttaccaaa
2581 ggtggtccgc tgccgttcgc ttgggacatc ctgtccccgc agttccagta cggttccaaa
2641 gcttacgtta aacacccggc tgacatcccg gactacctga aactgtcctt cccggaaggt
2701 ttcaaatggg aacgtgttat gaacttcgaa gacggtggtg ttgttaccgt tacccaggac
2761 tcctccctgc aagacggtga gttcatctac aaagttaaac tgcgtggtac caacttcccg
2821 tccgacggtc cggttatgca gaaaaaaacc atgggttggg aagcttccac cgaacgtatg
2881 tacccggaag acggtgctct gaaaggtgaa atcaaaatgc gtctgaaact gaaagacggt
2941 ggtcactacg acgctgaagt taaaaccacc tacatggcta aaaaaccggt tcagctgccg
3001 ggtgcttaca aaaccgacat caaactggac atcacctccc acaacgaaga ctacaccatc
3061 gttgaacagt acgaacgtgc tgaaggtcgt cactccaccg gtgcttaata acgctgatag
3121 tgctagtgta gatcgctact agagccaggc atcaaataaa acgaaaggct cagtcgaaag
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3181 actgggcctt tcgttttatc tgttgtttgt cggtgaacgc tctctactag agtcacactg
3241 gctcaccttc gggtgggcct ttctgcgttt ata
//
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C.2.5 2-way Linear Product
LOCUS

2-Way Linear Product

1050 bp ds-DNA

linear

2015
DEFINITION

.

FEATURES
misc_feature

Location/Qualifiers
120..141
/label="Biobrick Prefix Standard (RFC10)"

misc_feature

1..13
/label="exda22 5'overhang"

misc_feature

1..381
/label="2WL-Promoter"

misc_feature

354..1049
/label="2WL-BCP"

misc_feature

354..381
/label="2WL-overlap"

promoter

142..341
/label="R0010"

primer_bind

448..469
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27-JUN-

/label="pSBamil_for"
stem_loop

complement(80..83)
/label="end of terminator"

CDS

368..1036
/label="amilCP"

misc_feature

354..365
/label="exda12 5'overhang"

stem_loop

complement(93..112)
/label="Stem loop"

misc_feature

complement(371..381)
/label="exda23 5'overhang"

RBS

350..361
/label="B0034"

ORIGIN
1 TGAAGGATCA GCTTCTAAGA AACCATTATT ATCATGACAT TAACCtataa aaataggcgt
61 atcacgaggc agaatttcag ataaaaaaaa tccttagctt tcgctaagga tgatttctgg
121 aattcgcggc cgcttctaga gcaatacgca aaccgcctct ccccgcgcgt tggccgattc
181 attaatgcag ctggcacgac aggtttcccg actggaaagc gggcagtgag cgcaacgcaa
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241 ttaatgtgag ttagctcact cattaggcac cccaggcttt acactttatg cttccggctc
301 gtatgttgtg tggaattgtg agcggataac aatttcaCAC ATACTAGAGA AAGAGGAGAA
361 ATACTAGATG AGTGTGATCG CTAAACAAAT GACCTACAAG Gtttatatgt caggcacggt
421 caatggacac tactttgagg tcgaaggcga tggaaaaggt aagccctacg agggggagca
481 gacggtaaag ctcactgtca ccaagggcgg acctctgcca tttgcttggg atattttatc
541 accacagtgt cagtacggaa gcataccatt caccaagtac cctgaagaca tccctgacta
601 tgtaaagcag tcattcccgg agggctatac atgggagagg atcatgaact ttgaagatgg
661 tgcagtgtgt actgtcagca atgattccag catccaaggc aactgtttca tctaccatgt
721 caagttctct ggtttgaact ttcctcccaa tggacctgtc atgcagaaga agacacaggg
781 ctgggaaccc aacactgagc gtctctttgc acgagatgga atgctgctag gaaacaactt
841 tatggctctg aagttagaag gaggcggtca ctatttgtgt gaatttaaaa ctacttacaa
901 ggcaaagaag cctgtgaaga tgccagggta tcactatgtt gaccgcaaac tggatgtaac
961 caatcacaac aaggattaca cttcggttga gcagtgtgaa atttccattG CACGCAAACC
1021 TGTGGTCGCC TAATAATACT AGAGCCAGGC
//
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C.2.6 pUN Plasmid
LOCUS

T5-J23100-modBCP-GERC

4348 bp ds-DNA

2015
DEFINITION

.

FEATURES
terminator

Location/Qualifiers
complement(1813..1866)
/label="putative terminator"

misc_RNA

244..250
/label="cleaved 5'UTR"

promoter

complement(3771..3799)
/label="AmpR promoter"

misc_feature

1275..1314
/label="UNS9"

promoter

383..417
/label="J23100 (strong promoter)"

terminator

3910..4067
/label="rrnB terminator"

misc_feature

2086..2915
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circular

10-FEB-

/label="p15A origin"
terminator

complement(4255..4295)
/label="Sal2 terminator"

misc_binding

2754..2765
/label="Bsp24I site"

misc_binding

1907..1912
/label=""

terminator

4182..4226
/label="RNAI terminator"

misc_feature

244..318
/label="RiboJ"

primer_bind

119..158
/label="UNS7"

misc_feature

complement(1125..1164)
/label="UNS5"

terminator

complement(1441..1483)
/label="L17 terminator"

CDS

complement(2920..3729)
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/label="KanR"
terminator

1328..1381
/label="R2-17 terminator"

terminator

41..118
/label="B0055 Terminator (NCBI:AY643800)"

misc_feature

319..358
/label="UNS6"

enhancer

359..382
/label="Full UP Element"

misc_feature

204..243
/label="UNS4"

misc_feature

1..40
/label="UNSX"

promoter

159..203
/label="T5 promoter"

CDS

456..1124
/label="modified amilCP CDS"

ORIGIN

53

1 ccaggataca tagattacca caactccgag cccttccacc aaggaatatt cagcaatttg
61 cccgtgccga agaaaggccc acccgtgaag gtgagccagt gagttgattg ctacgtaaca
121 agacgctggc tctgacattt ccgctactga actactcgTC ATAAAAAATT TATTTGCTTT
181 GTGAGCGGAT AACAATTATA ATActgacct cctgccagca atagtaagac aacacgcaaa
241 gtcagctgtc accggatgtg ctttccggtc tgatgagtcc gtgaggacga aacagcctct
301 acaaataatt ttgtttaaCT CGTTCGCTGC CACCTAAGAA TACTCTACGG TCACATACGG
361 AAAATTTTTT TAAAAAAAAA ACTTTACAGC TAGCTCAGTC CTAGGTATTA TGCTAGCTAC
421 ATCCAATCGC CACTCAAATA AGGAGCACGT AAACAATGAG CGTTATCGCT AAACAAATGA
481 CCTACAAGGT TTATATGTCA GGCACGGTCA ATGGACACTA CTTTGAGGTC GAAGGCGATG
541 GAAAAGGTAA GCCCTACGAG GGGGAGCAGA CGGTAAAGCT CACTGTCACC AAGGGCGGAC
601 CTCTGCCATT TGCTTGGGAT ATTTTATCAC CACAGTGTCA GTACGGAAGC ATACCATTCA
661 CCAAGTACCC TGAAGACATC CCTGACTATG TAAAGCAGTC ATTCCCGGAG GGCTATACAT
721 GGGAGAGGAT CATGAACTTT GAAGATGGTG CAGTGTGTAC TGTCAGCAAT GATTCCAGCA
781 TCCAAGGCAA CTGTTTCATC TACCATGTCA AGTTCTCTGG TTTGAACTTT CCTCCCAATG
841 GACCTGTCAT GCAGAAGAAG ACACAGGGCT GGGAACCCAA CACTGAGCGT CTCTTTGCAC
901 GAGATGGAAT GCTGCTAGGA AACAACTTTA TGGCTCTGAA GTTAGAAGGA GGCGGTCACT
961 ATTTGTGTGA ATTTAAAACT ACTTACAAGG CAAAGAAGCC TGTGAAGATG CCAGGGTATC
1021 ACTATGTTGA CCGCAAACTG GATGTAACCA ATCACAACAA GGATTACACT TCGGTTGAGC
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1081 AGTGTGAAAT TTCCATTGCA CGCAAACCTG TGGTCGCCTA ATAACTCTAA CGGACTTGAG
1141 TGAGGTTGTA AAGGGAGTTG GCTCCTCGGT ACCAAATTCC AGAAAAGAGG CCTCCCGAAA
1201 GGGGGGCCTT TTTTCGTTTT GGTCCGGGAG ACCAGAAACA AAAAAAGGCC GCGTTAGCGG
1261 CCTTCAATAA TTGGGTTCCT TATCATCTGG CGAATCGGAC CCACAAGAGC ACTGtcgaga
1321 aggacacggt taatactagg cctgctggct ggtaatcgcc agcaggcctt tttatttggg
1381 ggagagggaa gtcatgaaaa aactaacctt tgaaattcga tctccaccac atcagctctg
1441 aagcaacgta aaaaaacccg ccccggcggg tttttttata cccgtagtat ccccacttat
1501 ctacaatagc tgtccttaat taatctagaa aaatgaaggg aagttcctat actttctaga
1561 gaataggaac ttctataggg agtcgaataa gggcgacaca aaaggtattc taaatgcata
1621 ataaatactg ataacatctt atagtttgta ttatattttg tattatcgtt gacatgtata
1681 attttgatat caaaaactga ttttcccttt attattttcg agatttattt tcttaattct
1741 ctttaacaaa ctagaaatat tgtatataca aaaaatcata aataatagat gaatagttta
1801 attataggtg ttcatcaatc gaaaaagcaa cgtatcttat ttaaagtgcg ttgctttttt
1861 ctcatttata aggttaaata attctcatat atcaagcaaa gtgacaggcg cccttaaata
1921 ttctgacaaa tgctctttcc ctaaactccc cccataaaaa aacccgccga agcgggtttt
1981 tacgttattt gcggattaac gattactcgt tatcagaacc gcccaggatg cctggcagtt
2041 ccctactctc gccgctgcgc tcggtcgttc ggctgcggga cctcagcgct agcggagtgt
2101 atactggctt actatgttgg cactgatgag ggtgtcagtg aagtgcttca tgtggcagga
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2161 gaaaaaaggc tgcaccggtg cgtcagcaga atatgtgata caggatatat tccgcttcct
2221 cgctcactga ctcgctacgc tcggtcgttc gactgcggcg agcggaaatg gcttacgaac
2281 ggggcggaga tttcctggaa gatgccagga agatacttaa cagggaagtg agagggccgc
2341 ggcaaagccg tttttccata ggctccgccc ccctgacaag catcacgaaa tctgacgctc
2401 aaatcagtgg tggcgaaacc cgacaggact ataaagatac caggcgtttc cccctggcgg
2461 ctccctcgtg cgctctcctg ttcctgcctt tcggtttacc ggtgtcattc cgctgttatg
2521 gccgcgtttg tctcattcca cgcctgacac tcagttccgg gtaggcagtt cgctccaagc
2581 tggactgtat gcacgaaccc cccgttcagt ccgaccgctg cgccttatcc ggtaactatc
2641 gtcttgagtc caacccggaa agacatgcaa aagcaccact ggcagcagcc actggtaatt
2701 gatttagagg agttagtctt gaagtcatgc gccggttaag gctaaactga aaggacaagt
2761 tttggtgact gcgctcctcc aagccagtta cctcggttca aagagttggt agctcagaga
2821 accttcgaaa aaccgccctg caaggcggtt ttttcgtttt cagagcaaga gattacgcgc
2881 agaccaaaac gatctcaaga agatcatctt attaagcttt tagaaaaact catcgagcat
2941 caaatgaaac tgcaatttat tcatatcagg attatcaata ccatattttt gaaaaagccg
3001 tttctgtaat gaaggagaaa actcaccgag gcagttccat aggatggcaa gatcctggta
3061 tcggtctgcg attccgactc gtccaacatc aatacaacct attaatttcc cctcgtcaaa
3121 aataaggtta tcaagtgaga aatcaccatg agtgacgact gaatccggtg agaatggcaa
3181 aagtttatgc atttctttcc agacttgttc aacaggccag ccattacgct cgtcatcaaa
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3241 atcactcgca tcaaccaaac cgttattcat tcgtgattgc gcctgagcga ggcgaaatac
3301 gcgatcgctg ttaaaaggac aattacaaac aggaatcgag tgcaaccggc gcaggaacac
3361 tgccagcgca tcaacaatat tttcacctga atcaggatat tcttctaata cctggaacgc
3421 tgtttttccg gggatcgcag tggtgagtaa ccatgcatca tcaggagtac ggataaaatg
3481 cttgatggtc ggaagtggca taaattccgt cagccagttt agtctgacca tctcatctgt
3541 aacatcattg gcaacgctac ctttgccatg tttcagaaac aactctggcg catcgggctt
3601 cccatacaag cgatagattg tcgcacctga ttgcccgaca ttatcgcgag cccatttata
3661 cccatataaa tcagcatcca tgttggaatt taatcgcggc ctcgacgttt cccgttgaat
3721 atggctcata ttcttccttt ttcaatatta ttgaagcatt tatcagggtt attgtctcat
3781 gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggtca gtgttacaac
3841 caattaacca attctgaaca ttatcgcgag cccatttata cctgaatatg gctcataaca
3901 ccccttgttt gcctggcggc agtagcgcgg tggtcccacc tgaccccatg ccgaactcag
3961 aagtgaaacg ccgtagcgcc gatggtagtg tggggactcc ccatgcgaga gtagggaact
4021 gccaggcatc aaataaaacg aaaggctcag tcgaaagact gggcctttcg cccgggctaa
4081 ttagggggtg tcgcccttat tcgactctat agggaagttc ctattctcta gaaagtatag
4141 gaacttctga aggggggctc gagcggccgc aaaaggaaaa gatccggcaa acaaaccacc
4201 gttggtagcg gtggtttttt tgtttggatc gacaatcttc gtaagcgtca tcaataagcg
4261 taaaaaaacc gggcaatgcc cggtttttta atgagaaatt ttacctgtcg tagccgccac
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4321 catccggcaa agaagcatac aaggcttt
//
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C.2.7 Pfu expression plasmid for ex vivo PCR
LOCUS

pUN-rhaBp-Pfu

5887 bp ds-DNA

2015
DEFINITION

.

FEATURES
-10_signal

Location/Qualifiers
280..285
/label="-10 region"

primer_bind

119..158
/label="UNS7"

RBS

302..335
/label="synRBS (60K TIR)"

terminator

complement(2980..3022)
/label="L17 terminator"

CDS

complement(4459..5268)
/label="KanR"

protein_bind

159..180
/label="CRP-cAMP binding site"

misc_binding

4293..4304
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circular

27-JUN-

/label="Bsp24I site"
terminator

2867..2920
/label="R2-17 terminator"

misc_feature

1..40
/label="UNSX"

misc_feature

3625..4454
/label="p15A origin"

terminator

complement(5794..5834)
/label="Sal2 terminator"

misc_feature

2814..2853
/label="UNS9"

-35_signal

259..264
/label="-35 region"

terminator

41..118
/label="B0055 Terminator (NCBI:AY643800)"

misc_signal

292..292
/label="TSS"

misc_feature

1221..1262
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/label="gBlock overlap"
protein_bind

244..260
/label="RhaS binding site"

promoter

159..301
/label="rhaBADp"

misc_feature

complement(2664..2703)
/label="UNS5"

CDS

336..2663
/label="PfuDNApol"

terminator

5721..5765
/label="RNAI terminator"

protein_bind

189..210
/label="CRP-cAMP binding site"

promoter

complement(5310..5338)
/label="AmpR promoter"

terminator

5449..5606
/label="rrnB terminator"

misc_binding

3446..3451

61

/label=""
misc_signal

264..269
/label="EcoRI site"

protein_bind

211..227
/label="RhaS binding site"

terminator

complement(3352..3405)
/label="putative terminator"

ORIGIN
1 ccaggataca tagattacca caactccgag cccttccacc aaggaatatt cagcaatttg
61 cccgtgccga agaaaggccc acccgtgaag gtgagccagt gagttgattg ctacgtaaca
121 agacgctggc tctgacattt ccgctactga actactcgcg gtgagcatca catcaccaca
181 attcagcaaa ttgtgaacat catcacgttc atctttccct ggttgccaat ggcccatttt
241 cctgtcagta acgagaaggt cgcgtattca ggcgcttttt agactggtcg taatgaaatt
301 cAATAAAGCA AGCAAACACT ATAAGGAGTC CGCACATGAT CCTGGATGTC GATTACATCA
361 CCGAAGAAGG CAAACCGGTG ATCCGTCTGT TCAAAAAAGA AAATGGTAAA TTCAAGATAG
421 AACACGATCG CACCTTTCGC CCTTATATTT ATGCACTGTT ACGCGATGAC AGCAAAATCG
481 AAGAAGTCAA AAAGATCACC GGCGAACGCC ACGGTAAAAT CGTGCGCATT GTTGATGTTG
541 AAAAAGTGGA GAAAAAATTC CTGGGCAAGC CAATTACTGT CTGGAAGCTC TACCTGGAAC
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601 ATCCGCAGGA TGTGCCGACG ATTCGTGAAA AGGTGCGTGA GCATCCCGCG GTGGTGGATA
661 TTTTTGAATA TGACATTCCG TTTGCCAAAC GGTATCTGAT TGATAAAGGG CTGATCCCGA
721 TGGAAGGTGA AGAGGAACTG AAAATTCTGG CATTTGATAT CGAAACGCTG TATCACGAAG
781 GTGAGGAGTT CGGCAAAGGC CCGATCATCA TGATCAGCTA CGCTGATGAA AATGAAGCAA
841 AAGTAATTAC CTGGAAAAAC ATCGACCTGC CGTATGTCGA AGTTGTTTCT TCAGAGCGCG
901 AAATGATTAA ACGCTTTTTA CGGATTATTC GCGAAAAAGA CCCAGACATC ATTGTCACCT
961 ACAACGGTGA CAGTTTCGAT TTCCCGTACC TTGCGAAGCG TGCAGAAAAA CTCGGCATTA
1021 AACTGACCAT TGGTCGTGAC GGCAGCGAGC CAAAAATGCA GCGTATTGGC GATATGACCG
1081 CCGTAGAAGT AAAAGGCCGT ATCCATTTTG ACCTTTATCA TGTTATCACT CGCACGATCA
1141 ACCTGCCAAC ATACACCCTC GAGGCGGTTT ATGAAGCGAT CTTCGGTAAG CCGAAAGAAA
1201 AAGTGTATGC CGATGAAATT GCGAAAGCGT GGGAATCCGG CGAGAATCTG GAACGTGTTG
1261 CCAAATACAG CATGGAAGAT GCCAAAGCTA CTTACGAATT GGGAAAAGAG TTTTTGCCAA
1321 TGGAGATTCA GCTGAGCCGC CTGGTTGGTC AGCCGCTGTG GGATGTATCC CGTTCTTCGA
1381 CGGGTAACCT GGTGGAATGG TTTCTCTTGC GTAAGGCTTA TGAGCGTAAC GAAGTGGCGC
1441 CGAACAAACC TTCTGAAGAA GAGTATCAGC GCCGTTTGCG CGAGAGTTAT ACCGGTGGTT
1501 TTGTGAAAGA ACCGGAGAAA GGATTATGGG AAAACATTGT CTATCTCGAC TTCCGCGCGC
1561 TGTATCCGTC TATTATTATC ACCCACAACG TGTCACCGGA TACCCTGAAC CTCGAAGGCT
1621 GTAAAAATTA CGATATTGCC CCGCAAGTCG GTCACAAATT TTGCAAAGAT ATCCCCGGAT
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1681 TTATTCCTTC GCTGCTGGGG CATCTGCTGG AAGAGCGGCA AAAAATTAAA ACGAAAATGA
1741 AAGAAACACA AGATCCGATT GAGAAGATTT TGCTCGATTA TCGCCAGAAA GCAATAAAAT
1801 TGCTGGCGAA CAGCTTCTAC GGCTACTACG GTTATGCGAA AGCCCGCTGG TATTGTAAGG
1861 AGTGCGCCGA AAGTGTCACT GCCTGGGGCC GCAAATATAT TGAACTGGTA TGGAAAGAGC
1921 TGGAAGAGAA GTTTGGTTTT AAAGTTCTTT ACATCGACAC CGATGGTCTG TACGCCACGA
1981 TTCCCGGCGG CGAAAGCGAA GAAATTAAGA AGAAAGCACT TGAATTTGTC AAGTATATCA
2041 ATTCGAAACT GCCTGGCCTG CTGGAGCTTG AGTACGAGGG GTTTTATAAA CGCGGTTTCT
2101 TTGTTACCAA AAAACGTTAT GCTGTGATTG ACGAAGAAGG GAAAGTCATT ACCCGCGGCT
2161 TAGAGATCGT TCGTCGCGAC TGGAGCGAAA TCGCCAAGGA AACTCAGGCG CGCGTGCTGG
2221 AAACCATCTT AAAACACGGC GACGTTGAGG AAGCCGTTCG CATTGTGAAG GAAGTGATTC
2281 AAAAGCTTGC CAACTACGAA ATCCCGCCGG AAAAACTGGC CATCTATGAA CAGATTACGC
2341 GTCCGCTGCA TGAATACAAA GCGATTGGGC CGCATGTCGC AGTGGCAAAA AAGCTGGCGG
2401 CAAAAGGTGT GAAAATCAAA CCGGGCATGG TGATCGGCTA TATCGTACTG CGTGGTGATG
2461 GCCCAATCAG TAATCGTGCG ATACTGGCTG AAGAATACGA CCCGAAGAAA CATAAATATG
2521 ATGCGGAATA TTACATTGAA AACCAGGTTC TGCCGGCGGT ATTACGTATT CTGGAGGGCT
2581 TTGGCTACCG TAAAGAGGAT CTGCGCTATC AAAAAACCCG TCAGGTGGGA CTGACGAGCT
2641 GGCTGAATAT CAAAAAAAGC TAACTCTAAC GGACTTGAGT GAGGTTGTAA AGGGAGTTGG
2701 CTCCTCGGTA CCAAATTCCA GAAAAGAGGC CTCCCGAAAG GGGGGCCTTT TTTCGTTTTG
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2761 GTCCGGGAGA CCAGAAACAA AAAAAGGCCG CGTTAGCGGC CTTCAATAAT TGGGTTCCTT
2821 ATCATCTGGC GAATCGGACC CACAAGAGCA CTGtcgagaa ggacacggtt aatactaggc
2881 ctgctggctg gtaatcgcca gcaggccttt ttatttgggg gagagggaag tcatgaaaaa
2941 actaaccttt gaaattcgat ctccaccaca tcagctctga agcaacgtaa aaaaacccgc
3001 cccggcgggt ttttttatac ccgtagtatc cccacttatc tacaatagct gtccttaatt
3061 aatctagaaa aatgaaggga agttcctata ctttctagag aataggaact tctataggga
3121 gtcgaataag ggcgacacaa aaggtattct aaatgcataa taaatactga taacatctta
3181 tagtttgtat tatattttgt attatcgttg acatgtataa ttttgatatc aaaaactgat
3241 tttcccttta ttattttcga gatttatttt cttaattctc tttaacaaac tagaaatatt
3301 gtatatacaa aaaatcataa ataatagatg aatagtttaa ttataggtgt tcatcaatcg
3361 aaaaagcaac gtatcttatt taaagtgcgt tgcttttttc tcatttataa ggttaaataa
3421 ttctcatata tcaagcaaag tgacaggcgc ccttaaatat tctgacaaat gctctttccc
3481 taaactcccc ccataaaaaa acccgccgaa gcgggttttt acgttatttg cggattaacg
3541 attactcgtt atcagaaccg cccaggatgc ctggcagttc cctactctcg ccgctgcgct
3601 cggtcgttcg gctgcgggac ctcagcgcta gcggagtgta tactggctta ctatgttggc
3661 actgatgagg gtgtcagtga agtgcttcat gtggcaggag aaaaaaggct gcaccggtgc
3721 gtcagcagaa tatgtgatac aggatatatt ccgcttcctc gctcactgac tcgctacgct
3781 cggtcgttcg actgcggcga gcggaaatgg cttacgaacg gggcggagat ttcctggaag
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3841 atgccaggaa gatacttaac agggaagtga gagggccgcg gcaaagccgt ttttccatag
3901 gctccgcccc cctgacaagc atcacgaaat ctgacgctca aatcagtggt ggcgaaaccc
3961 gacaggacta taaagatacc aggcgtttcc ccctggcggc tccctcgtgc gctctcctgt
4021 tcctgccttt cggtttaccg gtgtcattcc gctgttatgg ccgcgtttgt ctcattccac
4081 gcctgacact cagttccggg taggcagttc gctccaagct ggactgtatg cacgaacccc
4141 ccgttcagtc cgaccgctgc gccttatccg gtaactatcg tcttgagtcc aacccggaaa
4201 gacatgcaaa agcaccactg gcagcagcca ctggtaattg atttagagga gttagtcttg
4261 aagtcatgcg ccggttaagg ctaaactgaa aggacaagtt ttggtgactg cgctcctcca
4321 agccagttac ctcggttcaa agagttggta gctcagagaa ccttcgaaaa accgccctgc
4381 aaggcggttt tttcgttttc agagcaagag attacgcgca gaccaaaacg atctcaagaa
4441 gatcatctta ttaagctttt agaaaaactc atcgagcatc aaatgaaact gcaatttatt
4501 catatcagga ttatcaatac catatttttg aaaaagccgt ttctgtaatg aaggagaaaa
4561 ctcaccgagg cagttccata ggatggcaag atcctggtat cggtctgcga ttccgactcg
4621 tccaacatca atacaaccta ttaatttccc ctcgtcaaaa ataaggttat caagtgagaa
4681 atcaccatga gtgacgactg aatccggtga gaatggcaaa agtttatgca tttctttcca
4741 gacttgttca acaggccagc cattacgctc gtcatcaaaa tcactcgcat caaccaaacc
4801 gttattcatt cgtgattgcg cctgagcgag gcgaaatacg cgatcgctgt taaaaggaca
4861 attacaaaca ggaatcgagt gcaaccggcg caggaacact gccagcgcat caacaatatt
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4921 ttcacctgaa tcaggatatt cttctaatac ctggaacgct gtttttccgg ggatcgcagt
4981 ggtgagtaac catgcatcat caggagtacg gataaaatgc ttgatggtcg gaagtggcat
5041 aaattccgtc agccagttta gtctgaccat ctcatctgta acatcattgg caacgctacc
5101 tttgccatgt ttcagaaaca actctggcgc atcgggcttc ccatacaagc gatagattgt
5161 cgcacctgat tgcccgacat tatcgcgagc ccatttatac ccatataaat cagcatccat
5221 gttggaattt aatcgcggcc tcgacgtttc ccgttgaata tggctcatat tcttcctttt
5281 tcaatattat tgaagcattt atcagggtta ttgtctcatg agcggataca tatttgaatg
5341 tatttagaaa aataaacaaa taggggtcag tgttacaacc aattaaccaa ttctgaacat
5401 tatcgcgagc ccatttatac ctgaatatgg ctcataacac cccttgtttg cctggcggca
5461 gtagcgcggt ggtcccacct gaccccatgc cgaactcaga agtgaaacgc cgtagcgccg
5521 atggtagtgt ggggactccc catgcgagag tagggaactg ccaggcatca aataaaacga
5581 aaggctcagt cgaaagactg ggcctttcgc ccgggctaat tagggggtgt cgcccttatt
5641 cgactctata gggaagttcc tattctctag aaagtatagg aacttctgaa ggggggctcg
5701 agcggccgca aaaggaaaag atccggcaaa caaaccaccg ttggtagcgg tggttttttt
5761 gtttggatcg acaatcttcg taagcgtcat caataagcgt aaaaaaaccg ggcaatgccc
5821 ggttttttaa tgagaaattt tacctgtcgt agccgccacc atccggcaaa gaagcataca
5881 aggcttt
//
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